Metabolism of pyrrolizidine alkaloids by ruminal microbes by Craig, A. Morrie
AN ABSTRACT OF THE THESIS OF
Jeannette Talbot Hovermale for the degree of Doctor of Philosophy in Chemistry
presented on January 22. 1998.Title: Metabolism of Pyrrolizidine Alkaloids by
Ruminal Microbes.
AbstractapprovecRedacted for Privacy
A. Morrie Craig
The plantSenecio jacobaea(tansy ragwort) produces several macrocyclic
pyrrolizidine alkaloids which cause irreversible liver cirrhosis. All of the pyrrolizidine
alkaloids in Senecio jacobaea are macrocyclic diesters of the necine base
retronecine, with the two most predominant being seneciphylline and jacobine.
Unlike horses and cattle, sheep and goats are generally resistant to chronic
pyrrolizidine alkaloid toxicosis due to metabolism of the toxic pyrrolizidine alkaloids
by ruminal bacteria.
In this study, metabolism of jacobine and seneciphylline by ruminal bacteria
was investigated, focusing on two possible metabolic pathways. One pathway
involved hydrolysis of jacobine and seneciphylline and the subsequent production
of the necine base retronecine. For use in these studies, retronecinewas isolated
and labeled with deuterium. A method was developed for the determination of
retronecine to 0.02 pg /mL. Significant hydrolysis of jacobine and seneciphylline
was not observed in either ovine whole rumen fluid or with a mixed culture of
anaerobic microbes derived from ovine rumen fluid which metabolizes jacobineandseneciphylline. Direct metabolism of retronecine independent of the macrocyclic
pyrrolizidine alkaloids was also not observed.
The second metabolic pathway studied involved the production of the necine
base modified by the conversion of the 1,2-double bond to an external methylene
group.Previously this conversion has been observed during metabolism of
pyrrolizidine alkaloids by the organism Peptostreptococcus heliotrinreducens. In
this study, P. heliotrinreducens was used to convert the pyrrolizidine alkaloids
heliotrine and lasiocarpine to the known 1-methylene-pyrrolizidines. The mixed
culture of ovine anaerobic microbes also metabolized heliotrine and lasiocarpine
rapidly to identical methylene products. This mixed culture metabolized jacobine
and seneciphylline rapidly with production of very low levels of the corresponding
1-methylene compounds. In contrast, metabolism of jacobine or seneciphylline by
P. heliotrinreducens was not observed. The mixed culture has demonstrated the
abilityto metabolize a greater variety of pyrrolizidinealkaloids than P.
heliotrinreducens.
Although the metabolites of jacobine and seneciphylline were not
conclusively identified,it was determined that hydrolysis of jacobine and
seneciphylline is not occurring. The second pathway studied appears to be more
probable, with the production of 1-methylene compounds as intermediates, although
not as end-products.Metabolism of Pyrrolizidine Alkaloids by Ruminal Microbes
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Chapter 1
INTRODUCTION
BACKGROUND
Throughout the world, pyrrolizidine alkaloids are produced by nearly 8000
species of plants (Culvenor, 1980).Approximately 300 unique pyrrolizidine
alkaloids have been isolated and identified.Many pyrrolizidine alkaloids are
hepatotoxic to both livestock and humans, with the principle pathology being
irreversible liver cirrhosis with pronounced fibrosis and biliary hyperplasia. Large
scale pyrrolizidine alkaloid poisoning in humans has usually arisen from the
contamination of grains with pyrrolizidine alkaloid containing plants. Three major
instances have occurred in South Africa, the Central Asian Republics of the USSR,
and Jamaica. In South Africa in the 1920s, wheat was contaminated mainly with
Senecio burchellii and S. ilicifolius which caused bread poisoning. (Bull et al., 1968;
Cheeke and Shull, 1985; Kingsbury, 1964) This bread poisoning was found to be
similar to veno-occlusive disease found in humans in the West Indies and
elsewhere (Kingsbury, 1964).In India and Afghanistan in the early 1970s grain
contaminated with Crotalaria seeds also caused veno-occlusive disease (Cheeke
and Shull, 1985; Culvenor, 1978; Tandon et al., 1978). In central Asia (1931-1945)
cereal grains were contaminated with Heliotropium lasiocarpum (Bull et al., 1968).2
As recently as 1992, flour contaminated with Heliotropium spp. in Tadjikistan
caused 3,906 cases of toxic liver injury (Chauvin et al., 1993). Human poisoning
also can occur when herbal teas and medicines are contaminated with pyrrolizidine
alkaloid-containing plants.In Africa and the West Indies bush tea often is made
with plants of the Crotalaria and Senecio spp. (Cheeke and Shull, 1985), and
poisoning in the United States resulting from tea made from Senecio longilobus has
been reported (Stillman et al., 1977).
The majority of the plants implicated in livestock poisonings have belonged
to one of three genera: 1) Senecio 2) Crotalaria or 3) Heliotropium (Cheeke and
Shull, 1985; Hooper, 1978; Kingsbury, 1964). The species most often causing
outbreaks of pyrrolizidine alkaloid poisoning will be discussed here.All of the
diseases discussed affecting livestock are characterized by liver lesions and often
death by hepatic liver cirrhosis, and have after the fact been identified as cases of
pyrrolizidine alkaloid poisonings. Lung lesions are also involved in some cases,
most often when plants of the genera Crotalaria are involved.
The genus Senecio consists of more than 1200 species of plants (Kingsbury,
1964; Sharrow et al., 1988), several of which are linked with pyrrolizidine alkaloid
poisoning. Senecio jacobaea has been the cause of stomach staggers in Wales
(early 1800s), Pictou disease (horses and cattle) in Nova Scotia (<1860) and
Winton disease (horses and cattle) in New Zealand (Bull et al., 1968; Cheeke and
Shull, 1985; Hosking and Brandt, 1936; Kingsbury, 1964; Long, 1917). S. latifolius
has been identified as the cause of Molteno horse disease and cattle sickness (also
called dunziekte) in South Africa (Bull et al., 1968; Cheeke and Shull, 1985; Hosking3
and Brandt, 1936; Kingsbury, 1964; Long, 1917). In Norway, sirasyke disease, a
liver disease in calves, has been linked with S. aquacticus (Bull et al., 1968; Hosking
and Brandt, 1936; Kingsbury, 1964). In Czechoslovakia and South Bohemia, zdar
disease in horses has been linked with S. erracticus (Bull et al., 1968; Kingsbury,
1964). In the West Indies, veno-occlusive disease in animals has been linked with
Senecio spp. (Kingsbury, 1964). In Germany, Schweinsberger disease in horses,
which is a cirrhosis of the liver, has been linked with S. vemalis (Bull et al., 1968).
S. riddelli has caused walking disease in horses in the United States, (Bull et al.,
1968; Cheeke and Shull, 1985) and S. bumheffii has proven fatal to an ox (Long,
1917). Also in the United States, both S. longilobus and S. vulgaris have both
caused severe cattle losses (Cheeke and Shull, 1985; Johnson and Molyneux,
1984). On several occasions cattle losses in Australia have been attributed to S.
lautus, especially after feeding experiments induced sickness and death in calves
and pathological changes consistent with pyrrolizidine alkaloid poisoning (Noble et
al., 1994; Seawright et al., 1991b; Walker and Kirkland, 1981).Recently, S.
raphanifolius has been implicated in cases of pyrrolizidine alkaloid poisoning in yaks
(Winter et al., 1992, 1993, 1994) and S. selloi has been implicated in cases of
pyrrolizidine alkaloid poisoning in Argentinian cattle (Odriozola et al., 1994).
The genera Crotalaria also contains several species of plants which are
linked with pyrrolizidine alkaloid poisoning by various diseases affecting the liver.
Missouri bottom disease, or walking disease in horses has been attributed to C.
sagittalis in the United States, and C. dura in South Africa where it is called
jaagsiekte disease (Bull et al., 1968; Cheeke and Shull, 1985; Culvenor, 1980;4
Kingsbury, 1964). C. spectabilis has caused poisonings of swine and cattle in the
United States (Cheeke and Shull, 1985), and has also been linked with losses of
horses and fowl (Kingsbury, 1964). In western Australia, C. retusa has been linked
with Kimberley horse disease, or 'walkabout' (Bull et al., 1968; Cheeke and Shull,
1985), as well as major losses of fowl (Kingsbury, 1964).
In Australia, two pyrrolizidine alkaloid containing plants belonging to the
genera Heliotropium are known to cause severe losses of livestock. H. europaeum
has caused poisoning of sheep, cattle (Bull et al., 1968; Cheeke and Shull, 1985;
Kingsbury, 1964), and swine (Jones et al., 1981). Rather than the typical liver
cirrhosis type symptoms, both H. europaeum and H. lasiocatpum have been known
to cause a sudden hematogenous jaundice in sheep, which is characterized by an
abnormally high copper content in the liver (Bull et al., 1968; Culvenor, 1980;
Kingsbury, 1964).
Other pyrrolizidine alkaloid containing plants which are known to cause
problems are those in the genera Amsinckia and Trichodesma. A. intermedia has
caused poisoning of horses, cattle and swine, both experimentally and in the field
(Kingsbury, 1964).In the United States it has caused walking disease in horses
and hard liver disease in both cattle and swine (Bull et al., 1968; Cheeke and Shull,
1985; Kingsbury, 1964).T. incanum has been linked with suiljuk disease
(characterized by lesions in the liver and the lungs) of horses and cattle in central
Asia (Bull et al., 1968; Culvenor, 1980).
Veno-occlusive disease, whether described in animals or humans, is
considered to be the result of poisoning from the pyrrolizidine alkaloids contained5
in Crotalaria and Senecio spp. specifically (Kingsbury, 1964).Veno-occlusive
disease in characterized by fibrosis and occlusion of hepatic veins resulting from
endothelial damage and blood clotting (Johnson et al., 1985). Due to the formation
of lesions in the liver, the liver loses its ability to produce urea. Death is often a
result of the increased blood ammonia concentration and ammonia intoxication
(Kingsbury, 1964).
Variations in species susceptibility to pyrrolizidine alkaloid poisoning have
also been observed.Hooper (1978) has rated several species sensitivity to
pyrrolizidine alkaloid poisoning, based on the approximate ratio of the amount of
plant material required to induce poisoning. The ratios are, for sheep and goats,
200; mice, 150; rats, 50; cattle and horses, 14; chickens, 5; and swine, 1. Feeding
trials by Cheeke have yielded very similar ratios for these animals, and have also
measured the lethal dose for several other rodents and young poultry (Cheeke,
1984; Cheeke and Pierson-Goeger, 1983).Gerbils were found to be the most
resistant, consuming 36 times their body weight of plant material. Hamsters are
about the same as sheep and goats, and guinea pigs and rabbits are slightly more
sensitive, yet still fairly resistant. Chicks and turkey poults were both extremely
sensitive to pyrrolizidine alkaloid poisoning (Cheeke and Pierson-Goeger, 1983).
Goeger et al., (1982) demonstrated that goats are more resistant than cattle to
pyrrolizidine alkaloid poisoning, with the lethal dose being >100% of their initial body
weight. Swick et al. (1982b) demonstrated that although guinea pigs can consume
large quantities of S. jacobaea, they are not completely resistant to pyrrolizidine
alkaloid poisoning from this plant.6
A similar variation of species resistance to specific pyrrolizidine alkaloids is
also observed. Hopkirk and Cunningham (1936) were able to demonstrate the
resistance of guinea pigs to the pyrrolizidine alkaloid jacobine which had been
isolated from S. jacobaea.In the same trials, rats were very susceptible to the
alkaloid, developing liver lesions similar in type to those observed in cattle which
have ingested S. jacobaea.It has also been demonstrated that monocrotaline is
not toxic to guinea pigs (Chesney and Allen, 1973; Swick et al., 1982a) but that rats
are susceptible to poisoning by monocrotaline (Chesney and Allen, 1973).
Variations in resistance due to method of pyrrolizidine alkaloid introduction
have also been observed. Pierson et al. (1977) has shown that rabbits are resistant
to pyrrolizidine alkaloid poisoning when consuming a diet of S. jacobaea (112% of
body weight over 263 days), but that they are susceptible to pyrrolizidine alkaloid
poisoning when injected intraperitoneally with purified pyrrolizidine alkaloid isolated
from S. Jacobaea. Sheep, which are generally considered resistant to pyrrolizidine
alkaloid poisoning under chronic conditions, have been observed to ingest 200% of
their body weight of toxic plant over a one year period without symptoms (Craig et
al., 1986). Sheep are susceptible to acute toxicity caused by pyrrolizidine alkaloid
poisoning, and have died after a single intraperitoneal injection of alkaloids (Hooper,
1978).
As previously mentioned, sheep tend to be tolerant to ingestion of
pyrrolizidine alkaloid containing plants, but are not completely immune to the toxic
effects.In feeding trials with both sheep and cattle using S. longilobus, sheep
generally required twice as much plant material to display the same symptoms as7
cattle (Dollahite, 1972; Kingsbury, 1964). Although sheep are generally considered
to be resistant to the chronic hepatotoxic effects of pyrrolizidine alkaloid poisoning,
sheep can die after long periods of exposure to pyrrolizidine alkaloids.In some
cases these deaths have been attributed to copper toxicity because after exposure
to pyrrolizidine alkaloids, copper tends to accumulate in the liver (Bull et al., 1968;
Cheeke and Shull, 1985; Culvenor, 1980). In experimental feeding trials, both rats
and broiler chicks have also been observed to have high concentrations of copper
in the liver after exposure to pyrrolizidine alkaloids (Huan et al., 1992; Swick et al.,
1982a, 1982c).In feeding trials in which sheep were fed diets containing a
combination of H. Europaeum and copper, it was concluded that the combination
of the two substances enhanced the toxicity of each one individually and caused an
excessive accumulation of copper in the liver (Howell et al., 1991). A recent study
using rats being fed a combination of the pyrrolizidine alkaloid retrorsine and copper
concluded that toxicity was enhanced when compared to rats getting either
retrorsine or copper alone (Morris et al., 1994).
Pyrrolizidine alkaloids can cause either acute or chronic toxicity.Acute
pyrrolizidine alkaloid toxicity is the result of a large intake of pyrrolizidine alkaloids,
and seldom occurs under natural conditions (Kingsbury, 1964). Symptoms of acute
toxicity are a massive generalized hemorrhage and acute liver toxicity (Sharrow et
al., 1988). Under natural conditions chronic toxicity is more commonly observed.
Chronic toxicity is characterized by the gradual loss of liver function due to a
cirrhosis-like condition which is brought on by small daily doses over the course of
several weeks or months (Kingsbury, 1964; Sharrow et al., 1988).Chronic8
symptoms in an animal are often not observed until just a few daysor weeks before
it dies (Molyneux et al., 1988; Sharrow et al., 1988). Symptoms of cattle ingesting
chronic, lethal amounts of Senecio spp. plants include disinterest in food and
surroundings, signs of discomfort, gradual weight loss or failure to gain weight,a
dull rough coat, diarrhea or constipation, behavioral changes (stubbornness), and
intestinal edema develops (Sharrow et al., 1988). In the terminal stages, the animal
may pace incessantly and appear blind (Sharrow et al., 1988).
The total dose necessary to cause acute toxicity is generally less than that
obtained under conditions of chronic toxicity (Hooper, 1978; Kingsbury, 1964).
Sheep are capable of metabolizing pyrrolizidine alkaloids within their rumen (Craig
et al.,1992; Dick et al.,1963; Lanigan, 1970; Lanigan and Smith, 1970;
Wachenheim et al., 1992a), and under chronic conditions, the small daily dose
obtained may be completely metabolized, whereas a large intake of pyrrolizidine
alkaloid may overwhelm ruminal microbes ability to function (Craig et al., 1992).
This may explain why the chronic dose in sheep is approximately 100 times larger
than the acute dose (Hooper, 1978). Under chronic conditions in horses and cattle,
fatalities generally occur after ingestion of 10% of the animals body weight of toxic
plant, although there is some evidence to indicate that toxicity is dependent more
on the rate at which the dose is received, and not necessarily on the cumulative
dose (Johnson et al., 1985).9
PYRROLIZIDINE ALKALOID STRUCTURES
The chemical structures of pyrrolizidine alkaloids are complicated and very
diverse.Pyrrolizidine alkaloids are all alkylamine esters: a nitrogen containing
necine base attached through ester linkages to mono- or dicarboxylic necic acids.
Examples of both are shown in Figures 1.1 and 1.2. Over 350 pyrrolizidine alkaloids
have been structurally elucidated, and the number is continually growing (Logie et
al., 1994; Segall et al., 1991).
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Figure 1.1 Examples of necic acids.
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Figure 1.2 Examples of necine bases.10
The necic acid is typically C7-C10 in length, oxygenated and highly
branched.The necine base can have varying degrees of unsaturation and
stereochemistry. Although numerous necine bases have been identified, nearly half
of all pyrrolizidine alkaloids which have been structurally elucidated contain the
necine base retronecine. The pyrrolizidine alkaloids resulting from the combination
of the necic acids and bases are either single-branched monoesters, noncyclic
diesters or cyclic diesters, the latter of which are often referred to as macrocyclic
pyrrolizidine alkaloids (Cheeke and Shull, 1985). Examples of each are shown in
Figure 1.3.
In plants, pyrrolizidine alkaloids are present in two chemical forms, the free
base and the N-oxide (Bull et al., 1968; Mattocks, 1986; Molyneux et al., 1991).
Some studies have indicated that the N-oxides are not as toxic as the free base of
pyrrolizidine alkaloids, but other evidence suggests that the mode of pyrrolizidine
alkaloid introduction can have a dramatic influence on the toxicity (Mattocks, 1971).
In studies where N-oxides are given intraperitoneally they are about 1/5 as toxic as
the parent alkaloids (Bull et al., 1958; Downing and Peterson, 1968), but when given
orally they display nearly identical toxicity (Barnes et al., 1964; Mattocks, 1971;
Molyneux et al., 1991; Schoental and Magee, 1959). It has been proposed that the
nearly equivalent toxicity of the two forms could be due to the conversion of the N-
oxide to the free base within the rumen (Molyneux et al., 1991) or the intestine
(Mattocks, 1971). This conversion has been observed for heliotrine within the
rumen (Lanigan, 1970).11
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Figure 1.3 Examples of different types of pyrrolizidine alkaloids.12
Not all pyrrolizidine alkaloids are toxic, and the degree of toxicity can also be
associated with a pyrrolizidine alkaloids structural characteristics. Toxic pyrrolizidine
alkaloids all contain a 1,2 double bond in the necine base and a branch in the ester
group (Cheeke and Shull, 1985; Culvenor et al., 1976; Kingsbury, 1964; Schoental,
1968). Cyclic diesters are more toxic than non-cyclic diesters which are more toxic
than monoesters (Cheeke and Shull, 1985; Culvenor et al., 1976; Schoental, 1968).
Some evidence exists to suggest that pyrrolizidine alkaloids containing the necine
base heliotridine are generally more toxic than those containing the necine base
retronecine (Cheeke and Shull, 1985; Culvenor et al., 1976; Schoental, 1968).
Heliotridine and retronecine are structural isomers of each other with heliotridine
having an a-OH at C7 and retronecine having a 13-OH at C7, as shown in Figure 1.4
(Bull et al., 1968; Mattocks, 1986). This may by true only for natural pyrrolizidine
alkaloid compounds which are resistant to hydrolysis (Mattocks, 1981), although
there is evidence that the structure of the acid is more important than the
configuration of the base moiety (Mattocks and Bird, 1983), with necic acids
containing a,(3-unsaturation being more
toxic than saturated necic acids (Hincks HO
OH
HO
OH
et al., 1991).It has been proposed that/7
between similar necic acids, those with
acetoxy- or methoxy- groups are moreRetronecine Heliotridine
toxic than those with hydroxyl groupsFigure 1.4 Structures of retronecine
and heliotridine.
(Schoental, 1968).13
LIVER METABOLISM
After ingestion, pyrrolizidine alkaloids are absorbed into the bloodstream and
transported to the liver. Once in the liver there are several possible reactions that
can take place, as demonstrated in Figure 1.5 (Cheeke and Shull, 1985; Culvenor,
1980; Segall et al., 1991; Swick, 1984).The pyrrolizidine alkaloids could be
hydrolyzed to the corresponding necic acid and base, which are then excreted in the
urine (Eastman and Segall, 1982; Mattocks, 1981). The pyrrolizidine alkaloids could
also be converted to their corresponding N-oxides which, being highly water soluble,
are also excreted in the urine (Mattocks and White, 1971). Both of these pathways
are considered to be non-toxic pathways.
pyrrole 0
formation H hydrolysis
Dehydrosenecionine
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N
dehydropyrrolizidine (DHP)
Senecionine
H30
Senecic Acid Senecionine
N-oxide
Senecic Acid
CH
Retronecine
Figure 1.5 Major pathways of pyrrolizidine alkaloid metabolism in the liver.14
The third possible pathway is the bioactivation of the pyrrolizidine alkaloids.
This bioactivation of pyrrolizidine alkaloids occurs when they are oxidized by mixed
function oxidases to potentially toxic pyrroles which are more reactive than the
original alkaloid, and act as alkylating agents (Mattocks and White, 1971). The
presence of the 1,2-double bond greatly facilitates this conversion to pyrroles, and
the esters attached at C9 or C7 cause the pyrrolic metabolites to be very strong
alkylating agents (Culvenor et al.,1976).Once formed, these extremely
electrophillic alkylating agents either react almost immediately with nucleophiles in
the cell (Mattocks, 1969, 1978; Swick, 1984), or hydrolyze to the more stable
dehydroaminoalcohols (pyrroles of necine bases) which can react further or be
eliminated from the body (Mattocks, 1969; Peterson et al., 1972).
Initial methods used by numerous researchers to detect the pyrroles of
necine bases were not very sensitive, and they could not distinguish between the
pyrrole formed from retronecine or the pyrrole formed form heliotridine.Early
reports of the pyrrole formation assumed that if the parent pyrrolizidine alkaloid
contained retronecine, then the pyrrole of retronecine was the product, and likewise
for pyrrolizidine alkaloids which contained heliotridine.It has been shown that
actually, a racemic mixture of the two compounds is formed from pyrrolizidine
alkaloids containing either retronecine or heliotridine (Kedzierski and Buhler, 1985).
The racemic mixture of the two pyrroles is referred to as dehydropyrrolizidine (DHP).
The production of dehydroretronecine (most likely DHP) in vivo in rats given either
of the pyrrolizidine alkaloids monocrotaline (Hsu et al., 1973) or seneciphylline
(Kedzierski and Buhler, 1986) has been demonstrated.15
Pyrrolic metabolites that react with soluble cell constituents such as thiols,
then may be transported out of the liver.It has been shown in vitro, that
senecionine reacts, via dehydrosenecionine, with glutathione (GSH) to form a
soluble DHP-GSH conjugate (Reed et al., 1992). Also in vitro, dehydroretronecine
reacts with both cysteine and GSH (Robertson et al., 1977). In vivo experiments
have shown that retrorsine also reacts, via dehydroretrorsine, with glutathione to
form a soluble DHP-GSH conjugate (Yan and Huxtable, 1995). Pyrrolic metabolites
also react with thiol groups on hemoglobin, forming relatively stable thioethers
(Mattocks and Jukes, 1990a, 1990b, 1992; Seawright et al., 1991a). Detection of
these pyrrolic thioethers in both blood and tissues has been used as a method of
confirming pyrrolizidine alkaloid poisoning (Seawright et al., 1991a; Winter et al.,
1990, 1992, 1993).
Pyrrolic metabolites also react with macromolecules such as nucleic acids
or proteins, becoming covalently bound (Cheeke and Shull, 1985; Hsu et al., 1975;
Swick, 1984). Both of the pyrrolizidine alkaloids seneciphylline and senecionine
have been found to bind covalently to DNA in rat liver (Candrian et al., 1985). It has
been demonstrated in vitro, that dehydroretronecine reacts with nucleosides such
as deoxyguanosine (Robertson, 1982), guanosine, adenosine, deoxythymidine,
uridine, and with several nucleotides as well (Wickramanayake et al., 1985). Also
in vitro, dehydromonocrotaline reacts with the nucleosides deoxyadenosine,
deoxyguanosine, thymidine and deoxycytidine (Niwa et al., 1991), in addition to
causing DNA cross-linking (Wagner et al., 1993). Pyrroles cross-linking with DNA
in vitro has been observed (Kim et al., 1995; White and Mattocks, 1972), as well as16
pyrrolic metabolites bound in the liver of rats given the pyrrolizidine alkaloid
retrorsine (Mattocks and White, 1973). Also in vitro, dehydroretronecine produces
DNA cross-links (Reed et al., 1988).It has been demonstrated in vivo, that the
pyrrolizidine alkaloids monocrotaline and jacobine both produce DNA cross-links in
rats (Petry et al., 1984, 1986). In mice, the pyrrolizidine alkaloids senecionine and
seneciphylline both bind covalently to hepatic DNA, RNA and protein (Eastman et
al.,1982), and the pyrrolizidine alkaloid riddelliine causes an increase in
unscheduled DNA synthesis in mice (Mirsalis et al., 1993). The alkylation of DNA
with pyrroles impairs cell division, leading to liver cirrhosis which ultimately leads to
death (Cheeke and Shull, 1985).
The formation of pyrroles in the liver from various pyrrolizidine alkaloids
generally follows the same pattern as toxicity vs. structure, with the formation of N-
oxides following the opposite pattern.Studies in rats have shown that the
unesterified aminoalcohols (necine bases) are not metabolized to pyrroles
(Mattocks, 1978, 1981).Diesters form about 15 times more pyrroles than
monoesters, and cyclic diesters are more efficiently converted to pyrroles than
noncyclic diesters (Mattocks, 1978, 1981).It has also been noticed that
hydroxylation on the acid moiety decreases pyrrole formation, whereas acetylation
can reverse this (Mattocks, 1981).This is consistent with Schoental's (1968)
proposal that necic acids with acetoxy groups are more toxic than ones with
hydroxyl groups. It has been found that the more toxic the pyrrolizidine alkaloid, the
more stable is the corresponding pyrrole (Mattocks, 1978). Two factors which can
favor an alkaloids conversion to pyrrolic metabolites are a high lipid:water partition17
coefficient and sufficient steric resistance to inhibit ester hydrolysis (Mattocks,
1981). Also in rats, non-cyclic diesters form the highest levels of N-oxides, while
macrocyclic diesters yield very low levels of N-oxides (Mattocks and Bird, 1983).
Changes within the cell, including DNA cross-linking and inducement of
megalocytosis by various pyrrolizidine alkaloids also follows the same pattern as
toxicity vs. structure.In studies using bovine kidney epithelial cell cultures, the
macrocyclic a,13-unsaturated pyrrolizidine alkaloids tested induced the most DNA
crosslinking and were also the most potent inducers of megalocytosis (Hincks et al.,
1991; Kim et al., 1993, 1995). The macrocyclic pyrrolizidine alkaloid monocrotaline
which does not contain a,13-unsaturation and non-cyclic diesters (heliosupine and
latifoline) were both weak DNA cross-linkers and weak inducers of megalocytosis
(Hincks et al., 1991; Kim et al., 1993). The necine base retronecine produced only
barely detectable DNA cross-links at high concentrations and did not induce any
detectable megalocytosis (Hincks et al., 1991; Kim et al., 1995).
The production of pyrrolic metabolites in various species generally follows the
same pattern of species resistance, with susceptible species, such as mice,
hamsters and rats producing high levels of pyrroles and resistant species such as
guinea pigs producing low levels of pyrroles (Chu and Segall, 1991). The formation
of N-oxides generally follows the opposite pattern (Chu and Segall, 1991). Enzyme
assisted hydrolysis of pyrrolizidine alkaloids has been identified, with two
carboxylesterases being isolated from guinea pig hepatic microsomes which show
activity toward the pyrrolizidine alkaloids seneciphylline, monocrotaline, senecionine
and integerrimine (Dueker et al., 1992b).In guinea pigs, esterase hydrolysis18
accounted for 92% of the metabolized pyrrolizidine alkaloid, whereas rats displayed
no esterase activity under similar conditions (Dueker et al., 1992a). The enzyme
which converts senecionine to DHP has been shown to be the major enzyme for
bioactivation in rats, but not in guinea pigs (Chung and Buhler, 1994). It has also
been shown that glutathione-S-transferase, which converts jacobine to a soluble
conjugate with glutathione, is active in guinea pigs, but not in rats (Dueker et al.,
1994). The resistance of guinea pigs can be attributed to a combination of the low
conversion of pyrrolizidine alkaloids to pyrroles, the conversion of pyrrolizidine
alkaloids to soluble glutathione conjugates and N-oxides and the enzyme mediated
hydrolysis of pyrrolizidine alkaloids (Chu and Segall, 1991; Dueker et al, 1992a,
1992b, 1994).
As previously mentioned, non-esterified retronecine yields low amounts of
pyi-roles in rat livers (Mattocks, 1981). Likewise, when retronecine pyrrole, which
is a weak alkylating agent, was given to rats, liver lesions did not develop (Mattocks,
1970), although in vitro it does inhibit DNA synthesis (Armstrong and Zuckerman,
1971). When injected interperitoneally, dehydroheliotridine has caused acute
toxicity in rats, as well as chronic damage to the liver (Peterson et al., 1972); it has
also been shown to interact with DNA in vitro (Black and Jago, 1970). The diacetyl
retronecine pyrrole has been shown to produce liver lesions identical to those
produced by the pyrroles of the pyrrolizidine alkaloids retrorsine and monocrotaline
at similar dose levels (Mattocks, 1970). The author concluded that the differences
in the toxicities of various pyrrolizidine alkaloids are due to the different amounts of
each that are metabolized to pyrroles, and the different stabilities of the reactive19
metabolites within the cell. Mattocks (1970) has also suggested that the structure
of the acid moiety is not important at the site of the toxic reaction. Recent work has
confirmed that differences in the toxicities of various pyrrolizidine alkaloids is due
to the reactivity of the dehydroalkaloid to nucleophillic attack (Yan et al., 1995). The
more reactive the dehydroalkaloid, the greater the amount of conjugation with GSH
and alkylating with macromolecules, and thus direct toxic effects by the pyrrolizidine
alkaloids.
RUMEN METABOLISM
Many herbivores, such as sheep, goats, cattle, deer, and elkare ruminant
animals. That is, that rather than a having monogastric digestive system (like
humans), they have a segmented digestive system, with the first segment being the
rumen. The rumen is a highly reductive, anaerobic, fermentative organ which is
buffered by bicarbonate to pH=6.0-6.7 (Hungate, 1988).Digestion begins on
ingested plant material in the rumen, both chemically and biologically. Therumen
contains a large population of microflora, including bacteria (101' viable cells/mL
rumen contents), protozoa (105-106 ciliate protozoa/mL rumen contents) and
anaerobic fungi (103-105 zoospore/mL rumen contents) (Ogimoto and Imai, 1981;
Orpin and Job lin, 1988; Stewart and Bryant, 1988).This microflora performs
several functions for the ruminant animal. For example, it is estimated that protozoa
are responsible for one quarter to one third of the fiber digestion that occurs
(Williams and Coleman, 1988). Among bacteria thereare cellulose degraders,
starch degraders, pectin degraders, methane producers, andmany others (Brock20
and Madigan, 1988). The majority of rumen bacteria are obligate anaerobes,
meaning that the presence of oxygen is harmful or lethal to them (Brock and
Madigan, 1988; Hungate, 1988; Ogimoto and !mai, 1981). There are several
factors which can influence the size and composition of the population of microflora,
including diurnal variations, diet effects (composition and frequency of feeding),
seasonal variation, geographical location and species of ruminant (Dehority and
Orpin, 1988).
One of the major pyrrolizidine alkaloid containing plants in Australia is
Heliotropium europaeum, which contains several pyrrolizidine alkaloids, including
europine, heleurine, heliotrine, lasiocarpine and acetyl-lasiocarpine (Bull et al.,
1968; Mattocks, 1986). The most abundant pyrrolizidine alkaloids in H. europaeum,
heliotrine and lasiocarpine, both contain the necine base heliotridine.It has been
shown that sheep in Australia contain ruminal microbes which are capable of
detoxifying the pyrrolizidine alkaloids heliotrine and lasiocarpine. The conversion
of heliotrine to 7a-hydroxy-1-methylene-8a-pyrrolizidine, as shown by pathway A
in Figure 1.6, was observed when heliotrine was incubated with rumen liquor
(Culvenor et al., 1962; Dick et al., 1963). It has been shown that when lasiocarpine
is incubated with sheep rumen contents, 7a-angeloxy-1-methylene-8a-pyrrolizidine
is formed as shown by pathway C in Figure 1.6 (Lanigan and Smith, 1970). Lanigan
and Smith (1970) also demonstrated that both of the methylene compounds are
further converted to 7a-hydroxy-1a-methyl-8a-pyrrolizidine (pathways B and D in
Figure 1.6), but they found no evidence to indicate that the necine base ring system
gets broken down further (Lanigan, 1970).In separate experiments, the21
intermediate 7a-angeloxy-1-methylenepyrrolizidine was tested for hepatotoxicity in
rats, and was found to produce no liver damage (Culvenor et al., 1976).
When incubating the pyrrolizidine alkaloid heliotrine with sheep ruminal
contents, a lag time of anywhere between 6 and 40 hr has been observed (Dick et
al., 1963; Lanigan, 1970; Russell and Smith, 1968). The addition of pyrrolizidine
H3c_ ,CH3
`a-1 ocH3 occcH
013
O CH
Heliotrine
7a-hydroxy-
1-methylene-
8a-pyrrolizidine
Lasiocarpine
C
7a-angeloxy-
1-methylene-
8a-pyrrolizidine
N
7a-hydroxy-1a-methy1-8a-pyrrolizidine
?"3
H3c-c-a-1
oCHm43
Figure 1.6 Detoxification of pyrrolizidine alkaloids in Australian sheep rumen
fluid.22
alkaloid containing plants, such as H. europaeum to the diet of sheep, selects for
the bacteria involved in the detoxification of the pyrrolizidine alkaloids and increases
their numbers within the rumen.This greatly increases the rate at which the
alkaloids are metabolized (Lanigan, 1970), indicating that the bacteria responsible
for detoxifying the pyrrolizidine alkaloids are not prominent species among the
normal rumen microflora, but that when their specific substrate becomes available
they are able to reproduce and grow rapidly.The detoxification of heliotrine
involves a reductive cleavage which requires molecular hydrogen. The normal
population of rumen bacteria which produces methane also requires molecular
hydrogen. As both metabolic pathways are competing for hydrogen, the addition
of methane inhibitors to sheeps diet can stimulate the metabolism of pyrrolizidine
alkaloids in the rumen (Culvenor, 1978; Lanigan, 1972).
Two bacteria have been isolated form Australian sheep ruminal contents
which are able to convert selected pyrrolizidine alkaloids to their respective
methylene compounds. A small Gram-negative coccus isolated from the rumen
contents of Australian Merino sheep reductively cleaves heliotrine to heliotric acid
and the corresponding 1-methylene compound (7a-hydroxy-1-methylene-8a-
pyrrolizidine) when grown in a partially defined media under strict anaerobic
conditions (pathway A in Figure 1.6) (Russell and Smith, 1968). Lanigan (1976)
isolatedaGram-positivecoccus(Peptostreptococcusheliotrinreducens,
Anonymous, 1983a, 1983b; Ezaki and Yabuuchi, 1986) capable of converting
several mono- and diester pyrrolizidine alkaloids (heliotrine, europine, supinine and
lasiocarpine) to their corresponding 1-methylene type compounds whengrown in23
media, although corresponding 1-methyl type compounds were found only when the
pyrrolizidine alkaloids were incubated with sheep ruminal fluid. Some macrocyclic
diester pyrrolizidine alkaloids (crispatine and monocrotaline) were metabolized by
Peptostreptococcus heliotrinreducens at a slower rate than the monoesters, while
other macrocyclic diester pyrrolizidine alkaloids (anacrotine and retrorsine) were not
metabolized at all under similar conditions. Also, the necine base heliotridine and
the saturated pyrrolizidine alkaloids cynaustraline and sarracine were not
metabolized under similar conditions.
In the northwestern United States pyrrolizidine alkaloid poisoning of livestock
is caused by Senecio jacobaea, a weed commonly referred to as tansy ragwort.
Tansy ragwort was inadvertently introduced to North America in the late 1800s, was
first observed in Oregon in 1922, and has continued to spread throughout the
Pacific Northwest (Muth, 1968; Snyder, 1972). Cases of pyrrolizidine alkaloid
poisoning were first confirmed in the 1950s, and since that time, losses due to
pyrrolizidine alkaloid poisoning have risen steadily (Snyder, 1972).It takes only a
small amount of tansy ragwort, 2% of their body weight over a 20-day period, to be
toxic to cattle (Johnson, 1978). The two most abundant pyrrolizidine alkaloids found
in tansy ragwort are jacobine and seneciphylline, with senecionine, jacoline,
jaconine, and jacozine also being present in lesser amounts (Bull et al., 1968;
Mattocks, 1986).All of these pyrrolizidine alkaloids contain the necine base
retronecine (Mattocks, 1986).
In the United States, resistance of sheep to pyrrolizidine alkaloid poisoning
has been observed, and in places infested with Senecio spp., sheep have been24
used as a biological control agent. Using sheep to graze an area before allowing
cattle into the area has reduced the losses due to Senecio poisoning (Dollahite,
1972; Muth, 1968). Intense grazing of tansy ragwort infested pasture by sheep, in
addition to eliminating established plants, also reduces seed production, thus
resulting in an overall reduction of the tansy ragwort population (Sharrow and
Mosher, 1982).
Initial experiments to determine if the sheep in the United Statesowe their
resistance to pyrrolizidine alkaloid poisoning from tansy ragwort to ruminal microbes
yielded negative results.Experiments were conducted in which ground tansy
ragwort was incubated with strained rumen fluid from sheep or cattle, and then the
resulting material was incorporated into the diet of rats (Shull et al., 1976).
Autoclaved rumen fluid incubated with tansy ragwort from either cattle or sheep
provided protection from pyrrolizidine alkaloid poisoning, as did the cattle rumen
fluid incubated with tansy ragwort, but the sheep rumen fluid incubated with tansy
ragwort did not provide protection.Further experiments were done in a similar
manner with sheep ruminal fluid from animals exposed to tansy ragwort in their diet
(Swick et al., 1983). These results also indicated that there was no difference in
pyrrolizidine alkaloid toxicity from untreated tansy ragwort and tansy ragwort
incubated with sheep ruminal fluid.Also in these incubations, methylene
intermediates similar to those identified as metabolites of heliotrine and lasiocarpine
in incubations with sheep ruminal fluid were searched for, but not found.
Craig et al. (1986) were the first to demonstrate that protection against
pyrrolizidine alkaloid poisoning occurred within the digestive tract of sheep. In these25
experiments sheep and calves both had a chronic indwelling catheter surgically
implanted in the portal vein of the liver. Through this catheter pyrrolizidine alkaloids
isolated from tansy ragwort were introduced directly to the liver, thus by-passing the
entire digestive tract.All of the animals which received a pyrrolizidine alkaloid
infusion, both sheep and calves, developed clinical, enzymatic and histopathologic
signs of pyrrolizidine alkaloid poisoning, at comparable doses of pyrrolizidine
alkaloid. Sheep given twice the dose of pyrrolizidine alkaloid orally did not show any
of the symptoms of pyrrolizidine alkaloid poisoning. The authors concluded that this
was due to either a protective mechanism in the rumen or a lack of absorption
and/or metabolism of the alkaloid in the gastrointestinal tract.
Subsequent work has shown the ability of sheep ruminal microbes to detoxify
the pyrrolizidine alkaloids containedin tansy ragwort (Craig etal.,1992;
Wachenheim et al., 1992a, 1992b). When unstrained sheep ruminal fluid is
incubated with pyrrolizidine alkaloids isolated from tansy ragwort at a concentration
of 100 pg/mL, the pyrrolizidine alkaloids disappear in less than 24 hr, while in sterile
controls, the pyrrolizidine alkaloid concentration remains constant throughout the
entire incubation period (Craig etal.,1992; Wachenheim etal.,1992a).
Pyrrolizidine alkaloids were observed to be metabolized under methanogenic
conditions but not under denitrifying conditions (Craig et al., 1992).It has been
concluded that the pyrrolizidine alkaloids are metabolized by a consortium of small
bacteria, with gram-positive bacteria being critical members (Craig et al., 1992;
Wachenheim et al., 1992b).26
In addition to sheep rumen fluid, the ability of goat and cow rumen fluid to
detoxify pyrrolizidine alkaloids has also been evaluated (Wachenheim et al., 1992a).
With pyrrolizidine alkaloids isolated from tansy ragwort, the rate of pyrrolizidine
alkaloid biotransformation was nearly the same in sheep and goat ruminal fluid, but
the rate in cow rumen fluid was 5-6 times slower. This slower rate of pyrrolizidine
alkaloid metabolism is most likely a result of a smaller population of pyrrolizidine
alkaloid degrading bacteria/mL of rumen fluid within the cow vs. the sheep or goat.
The authors estimated that in cows, pyrrolizidine alkaloid biotransforming bacteria
constitute 0.1% of the overall rumen bacterial population, whereas in sheep and
goats it is about 0.3%. It could be concluded that the larger number of pyrrolizidine
alkaloid degrading bacteria allows for increased rates of pyrrolizidine alkaloid
metabolism and therefore increased protection from pyrrolizidine alkaloid poisoning
(Wachenheim et al., 1992a).
As previously mentioned, work by other groups has not been able to show
that detoxification of pyrrolizidine alkaloids occurs in sheep ruminal fluid (Shull et al.,
1976; Swick et al., 1983), while work in our laboratory has been able to provide
consistent evidence of pyrrolizidine alkaloid detoxification by sheep ruminal fluid.
Several factors could be responsible for the success of the latter group, including
utilization of ruminal solids, anaerobic techniques, blending of ruminal contents,
agitation during incubation, uniform sampling times (shortly after feeding), pre-
exposure of animals to pyrrolizidine alkaloids and individual differences among
animals (Wachenheim et al., 1992a, 1992b).Some of the animals in the
experiments done by other groups were pre-exposed to tansy ragwort, but at very27
high levels (50% tansy ragwort in their diet) (Swick et al., 1983). This is consistent
with our findings that higher levels of pyrrolizidine alkaloids within the rumen fluid
requires longer incubation times for pyrrolizidine alkaloid disappearance to be
observed, and that there may be a toxic threshold above which metabolism of
pyrrolizidine alkaloids in sheep ruminal fluid cannot be demonstrated (Craig et al.,
1992).
In our laboratory attempts which have been made to isolate and identify the
microbes responsible for metabolizing the pyrrolizidine alkaloids have resulted in a
mixed culture of 4-6 anaerobic microbes (L4M2) which is capable of metabolizing
the pyrrolizidine alkaloids isolated from tansy ragwort. When these microbes are
separated and grown as individual pure cultures, none of them have demonstrated
the ability to metabolize the pyrrolizidine alkaloids; only when grown as a mixture
do they degrade pyrrolizidine alkaloids.
THESIS OVERVIEW
Recent research in this laboratory has focused on the mechanism of
pyrrolizidine alkaloid metabolism, both in incubations with whole rumen fluid and
with the pyrrolizidine alkaloid metabolizing mixed culture.Metabolism of the
pyrrolizidine alkaloids may involve a small structural change which renders them
unavailable for the conversion in the liver to the toxic pyrrole form.It is also
possible that more complete metabolism is occurring, including degradation of the
necine base. Indirect evidence has indicated that the necine base is degraded.
The mass spectra of pyrrolizidine alkaloids have mass/charge ratio signals (m/z)28
which are characteristic of the particular necine base present in the pyrrolizidine
alkaloid. Pyrrolizidine alkaloids which contain saturated necine bases generally
have signals at 82, 95-97, 122-123, and 138-140 (Bull et al., 1968; Mattocks, 1986).
Pyrrolizidine alkaloids which contain necine bases with a 1,2 double bond (suchas
retronecine) generally have signals 2 units less, at 80, 93-95, 119-121, and 136-139
(Bull et al., 1968; Mattocks, 1986). The largest signals in the mass spectra of the
pyrrolizidine alkaloids contained in tansy ragwort are 93, 120, and 136.If the
metabolism of these pyrrolizidine alkaloids involves degradation of the ring system,
the metabolites would not have the characteristic signals of the necine base ring
system. Preliminary studies based on this premise have indicated that metabolites
containing a necine base ring system are not being produced.
In an attempt to conclusively identify metabolites of the pyrrolizidine
alkaloids, two possible metabolic pathways involving the necine base were
investigated (Figure 1.7). The first possible metabolic pathway involves hydrolysis
of the pyrrolizidine alkaloids with the production of retronecine as an end-product
or a transient intermediate (pathway A in Figure 1.7).The second possible
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metabolic pathway investigated involves production of the necine base which has
been converted to a methylene compound, similar to those produced during the
metabolism of heliotrine and lasiocarpine by Peptostreptococcus heliotrinreducens,
as described previously (pathway B in Figure 1.7).
Hydrolysis of pyrrolizidine alkaloids in the rumen would result in the necine
base retronecine, a product consistent with the lack of toxicological effects observed
in sheep. Retronecine would be absorbed and transported to the liver, but since the
mixed function oxidase systems show very little activity towards retronecine, it would
not be converted to toxic pyrroles but instead excreted in the urine (Mattocks, 1978,
1981). The mixed culture of pyrrolizidine alkaloid metabolizing microbes contains
anywhere from four to six microbes, each of which may play a part in the
metabolism. One or more organisms could be hydrolyzing the ester linkages,
producing the necic acid and the necine base retronecine. Other organisms in the
mixed culture could be further metabolizing retronecine.If this is the case,
retronecine may be observed as a transient intermediate during the metabolism of
pyrrolizidine alkaloids. Retronecine will not be observed if its' rate of metabolism
is significantly faster than the rate of pyrrolizidine alkaloid metabolism.Also,
retronecine should be metabolized independently of the parent pyrrolizidine
alkaloids. In an effort to confirm this, it was decided that a labeled compound would
be useful in tracking and identifying the metabolites directly.
Few pyrrolizidine alkaloids are available commercially, and noneare
available commercially with a label of any kind. Labelled pyrrolizidine alkaloids have
been obtained by growing pyrrolizidine alkaloid producing plants ina growth30
chamber saturated with 14CO2, and then isolating the labelled pyrrolizidine alkaloids
from the plant material (Dueker et al., 1992a; Eastman et al., 1982; Estep et al.,
1991; Segall et al., 1983).Tritium labelled pyrrolizidine alkaloids have been
obtained by feeding pyrrolizidine alkaloid producing plants nutrients containing [2,3-
3H]putrescine hydrochloride and then isolating the labelled pyrrolizidine alkaloids
from the plant material (Candrian et al., 1985). Other precursors which have been
tested are omithine (both 3H and 14C labelled) and spermine (14C labelled) (Reed et
al., 1985). These labelling methods take a considerable amount of time, specialized
knowledge and equipment, and generally yield < 2% recovery of label into the
desired compounds (Reed et al., 1985).
Necine bases, although not available commercially, are accessible.In
particular, retronecine can be isolated from the commercially available pyrrolizidine
alkaloid monocrotaline, and subsequently labelled at the C-9 position (Hsu and
Allen, 1975; Mattocks, 1977; Mattocks, 1982). For use in determining if retronecine
is a transient intermediate during pyrrolizidine alkaloid metabolism, the necine base
retronecine was isolated and labelled for use in subsequent experiments. Details
of its purification and labelling are included in this study in Chapter 2.The
commercially available pyrrolizidine alkaloid monocrotaline was hydrolyzed to yield
retronecine. Procedures for the hydrolysis were similar to those in the literature
(Hoskins and Crout, 1977) but the cleanup method was improved upon. The
retronecine obtained was then oxidized and subsequently reduced, using a
deuterated reducing agent, which yielded retronecine deuterated in the C-9 position.
Methods of oxidation used previously yielded several side products and resulted in31
a low overall percent yield of the desired products (Hsu and Allen, 1975; Mattocks,
1982). The research presented here utilized a new application of the Dess-Martin
oxidizing agent periodinane (Dess and Martin, 1983, 1991) for thepurpose of
oxidizing retronecine. This resulted in less side products being formed anda higher
recovery than had been previously reported in the literature.
A method for the determination of retronecine from biological matrices was
developed. Details of the method and its development are included in this study in
Chapter 3.The procedure included derivatization with N-heptafluorobutyryl-
imidazole (HFBI) followed by GC/FID analysis and confirmation by GC/MS. The
method works for samples from whole rumen fluid as well as for samples from
bacterial growth media. Also presented in this study in Chapters 3 and 4 are the
results of experiments which demonstrated that hydrolysis is not a significant
mechanism in the metabolism of pyrrolizidine alkaloids.Incubations were
conducted with both sheep whole rumen fluid and the pyrrolizidine alkaloid
metabolizing mixed culture.Analysis indicated that although the pyrrolizidine
alkaloids were observed to disappear over time, retronecine was not detected as
an intermediate in any of the samples. Also, retronecine was not metabolized under
these conditions.
As mentionedpreviously,the second possible metabolic pathway
investigated involves the production of the necine base which has been converted
to a methylene compound (pathway B in Figure 1.7). These products would be
similar to those produced during the metabolism of heliotrine and lasiocarpine by
Peptostreptococcus heliotrinreducens. Details of this study are included in Chapter32
5. This organism (available via the American Type Culture Collection) was initially
grown on monocrotaline, which was completely metabolized in two to three weeks.
From these cultures, the corresponding methylene intermediate was identified with
GC/MS analysis. This organism was also grown (in individual cultures) on heliotrine
or lasiocarpine, from which the corresponding methylene intermediates were
identified with GC/MS analysis.Peptostreptococcus heliotrinreducens did not
metabolize jacobine or seneciphylline. In similar experiments with the mixed culture
L4M2 which metabolizes jacobine or seneciphylline, heliotrine and lasiocarpine were
metabolized to 1-methylene compounds (identified with GC/MS). These products
were identical to those produced from heliotrine and lasiocarpine by P.
heliotrinreducens. L4M2 also produced very low levels of the corresponding 1-
methylene compounds from jacobine and seneciphylline, although more extensive
metabolism is occurring.
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ABSTRACT
The necine base retronecine (la), common to numerous toxic pyrrolizidine
alkaloids, has previously been labelled with 3H at C-9 for use in metabolic studies.
The current method for labelling retronecine is inefficient, and we report herean
improvedmethodwhichutilizestheDess-Martinperiodinanereagent.
Characterization of the resulting aldehyde (2) is described. The overall yield of C9-
2H- retronecine (1b) is 71% (from la).
INTRODUCTION
Toxic plants containing pyrrolizidine alkaloids are common throughout the
world and are responsible for the death of livestock as well as humans (Bull et al.,
1968; Kingsbury, 1964; Mattocks, 1986; Snyder, 1972). All pyrrolizidine alkaloids
contain an amine portion, known as a necine base, that is usually attached through
one or more ester linkages to a necic acid portion. There are some 6,000 plants
that contain a total of at least 180 known pyrrolizidine alkaloids (Bull et al., 1968;
Mattocks, 1986; World Health Organization, 1988). The most toxic of these are
cyclic diesters, also known as macrolactone pyrrolizidine alkaloids, usually
containing the unsaturated necine base retronecine (la)(Bull et al., 1968;
Mattocks, 1981; Mattocks, 1986; World Health Organization, 1988).
Irreversible liver cirrhosis occurs in cattle when they ingest pyrrolizidine
alkaloid containing plants at as little as 5% of their body weight (Bull et al., 1968;
Craig et al., 1991; Cheeke, 1984; Dollahite, 1972; Ford et al., 1968; Thorpe and42
Ford, 1968). In contrast, the ingestion of these same plants by sheep at 200-300%
of their body weight produces no such effect (Cheeke, 1984; Dollahite, 1972;
Kingsbury, 1964). The resistance of sheep to these toxins has been attributed to
a consortium of bacteria contained within sheep rumen, that detoxify pyrrolizidine
alkaloids before they come into contact with the liver (Craig et al., 1986, 1992;
Lanigan, 1976; Wachenheim et al., 1992a, 1992b). We required retronecine for our
research in order to determine how sheep ruminal bacteria detoxify pyrrolizidine
alkaloids.
Studies involving pyrrolizidine alkaloids are often hindered by the difficulty in
obtaining large quantities of the pure compounds (Craig et al., 1986; Eastman et al.,
1982; Mattocks, 1981, 1977b; Segall et al., 1983). For this reason, semisynthetic
derivatives of pyrrolizidine alkaloids, both labelled and unlabelled, have been used
in several metabolic studies to simulate the toxic effects of pyrrolizidine alkaloids
and to elucidate the origin of their toxicity (Cheeke, 1984; Craig et al., 1991;
Dollahite, 1972; Eastman et al., 1982; Ford et al., 1968; Mattocks, 1977b; Thorpe
and Ford, 1968).Since the necine base has been implicated in the toxicity of
pyrrolizidine alkaloids, several studies have employed the more accessible necine
base retronecine (Cheeke, 1984; Craig et al., 1991; Dollahite, 1972; Ford et al.,
1968; Mattocks, 1977b; Thorpe and Ford, 1968).
The current method for labelling retronecine is inefficient (10-30% overall
yield) (Hsu and Allen, 1975; Mattocks, 1982). The only published method involves
a selective manganese dioxide oxidation (Hsu and Allen, 1975; Mattocks, 1977a,
1977b, 1982; Piper et al., 1981; Shumaker et al., 1978) followed by reduction of the43
resultant aldehyde with a labelled reducing reagent, such as LiAI3H4 (Hsu and Allen,
1975) or NaB3H4 (Mattocks, 1977b, 1982; Piper et al., 1981; Shumaker, et al.,
1978).The manganese dioxide oxidation affords a variety of undesired side
products and the isolation is further complicated because the desired aldehyde (2)
can not be stored or purified (Mattocks, 1977a). We report an improved method for
isolating retronecine (1) and for deuterating retronecine at C-9 by utilizing a more
selective method of oxidation (Figure 2.1).
3
la R=H
b R=D
2
Figure 2.1 Reaction scheme for the conversion of monocrotaline (3) to
retronecine (la), followed by oxidation to the aldehyde (2) and reduction to
deuterated retronecine, (1 b).
EXPERIMENTAL
Melting points were measured on a Buchi melting point apparatus and are
uncorrected.Infrared spectra were recorded on a Nicolet 5DBX FT-IR
spectrophotometer. Optical rotations were measured in 1-dm cells (1 mL capacity)
on a Perkin Elmer Model 243 polarimeter at ambient temperature.Nuclear
magnetic resonance spectra were recorded on a Bruker AM-300 spectrometer in44
D20 or CDCI3 for 1H and 13C nmr, and in CHCI3 for 2H nmr. Chemical shifts are
given in ppm relative to the solvent peak, either HOD in D20 or CHCI3 in CDCI3 for
the 1H and 13C nmr, or natural abundance CDCI3 in CHCI3 for the 2H nmr. Mass
spectra and exact mass determinations were obtained on a Varian MAT 311
spectrometer.
Retronecine (1a)
A mixture of a saturated aqueous solution of Ba(OH)2 prepared from
Ba(OH)28H20 (4.0 g, 13 mmol) and water (20 mL), and crystalline monocrotaline
(1.9667 g, 6.04 mmol) was stirred for 2 h at 40-50 °C, and then refluxed for 2 h.
After cooling to room temperature, solid CO2 was added, and the resultant mixture
was then kept at room temperature for 16 h. The solution was filtered through filter
paper, and the solvent was removed under reduced pressure. The residue was
purified by flash column chromatography on silica gel (CHCI3:MeOH:Et3N (13:5:2)),
which yielded 0.8523 g (91%) of a light tan solid. Recrystallization from hot acetone
produced pure retronecine as white crystals with mp 108 °C. [a]20D +52.7° (c=0.67,
EtOH). Ir v(film): 3400, 2940, 2850, 1635 cm-1. 1H Nmr (D20) 6 1.84 (2H, br m),
2.60 (1H, br m), 3.13 (1H, br m), 3.29 (1H, ddd, J=2.0, 4.9, 15.5 Hz), 3.72 (1H, dt,
J=3.5, 15.4 Hz), 4.12 (3H, br m), 4.28 (1H, br m), 5.63 (1H, s). 13C Nmr (D20) 6 35,
53, 58, 61, 71, 76, 125, 137. High resolution mass spectra calculated for C81-113NO2
155.0946, found 155.09460.45
[9-21-1]-Retronecine (1b)
To a stirred dichloromethane solution (5 mL) of Dess-Martin periodinane
(305.8 mg, 0.721 mmol) and CF3CO2H (60 pL, 0.616 mmol) was added a
dichloromethane solution (25 mL) of retronecine (100.6 mg, 0.648 mmol). The
resultant mixture was stirred for 1 h, after which dry ether (100 mL) was added. The
resultant precipitate was filtered and washed successively with ether. The volume
of the filtrate was reduced below 15°C under reduced pressure to approximately 3
mL to afford a solution of the crude, unstable, aldehyde (2) which was used without
purification. Ir v(film): 3400, 1680 cm-1. 1H Nmr (CDCI3) 5 2.25 (3H, br m), 3.14 (1H,
br m), 3.94 (2H, br m), 4.78 (2H, br m), 5.15 (1H, d, J=1.7 Hz), 6.81 (1H, q, J=2.0,
4.1 Hz), 9.80 (1H, s).High resolution mass spectra calculated for C8H11NO2
153.0790, found 153.07900.
Methanol (10 mL) was added to the crude aldehyde solution (.3 mL) and the
mixture was cooled to 0 °C, followed by the addition of NaB2H4 (175 mg, 4.18
mmol). The reaction was monitored by tic (silica gel, CHCI3:MeOH:Et3N (13:5:2)),
until all of the starting material was consumed (.30 min). The solvent was removed
under reduced pressure and the crude product was purified by flash column
chromatography (silica gel, CHCI3:MeOH:Et3N (13:5:2)), to yield a light tan solid
(71.9 mg, 71% from la).Ir v(film): 3400, 2940, 1640 cm-1. 1H Nmr (D20) 5 1.85
(2H, br m), 2.61 (1H, br m), 3.14 (1H, br m), 3.29 (1H, dt, J=5.0, 15.5 Hz), 3.73 (1H,
dd, J=1.6, 15.5 Hz), 4.10 (2H, br m), 4.29 (1H, br m), 5.64 (1H, s). 13C Nmr (D20)
6 35, 53, 58 (t), 61, 71, 76, 125, 137. 2H Nmr (CHCI3) 5 4.18 (1D, s), 4.38 (1D, s).
High resolution mass spectra calculated for C8H12DN02156.1009, found 156.10090.46
RESULTS AND DISCUSSION
Monocrotaline is efficiently hydrolyzed with Ba(OH)2 as previously reported,
but its purification involves a tedious isolation procedure (Hoskins and Crout, 1977).
The crude product mixture obtained after hydrolysis and treatment with CO2 is most
efficiently purified by column chromatography on silica gel using a ternary solvent
system (CHCI3:MeOH:Et3N).With this new protocol, we have obtained pure
retronecine in up to 95% yield on a 5-gram scale.
Having obtained large quantities of retronecine, we next developed an
efficient method forpreparingC9-2H-retronecine.We reasoned that a
chemoselective oxidation of retronecine would be more efficient and might be
achieved using the Dess-Martin periodinane reagent. This reagent could potentially
differentiate between the two alcohol functions because of their difference in steric
environments. In addition, the enhanced reactivity of the Dess-Martin periodinane
with benzylic alcohols (Dess and Martin, 1983, 1991) suggested that the rate of
reaction with the allylic alcohol moiety may be faster than with the alcohol function
at C7.
In practice, oxidation of retronecine with Dess-Martin periodinane proceeded
cleanly and quickly (less than 1h).Our experiments indicate that oxidizing
retronecine with periodinane yields two products, the major product being the
desired aldehyde (2). The aldehyde (2) has been reported previously, although the
respective nmr signals have not been unambiguously assigned (shown in Figure
2.2). Table 2.1 contains the complete chemical shift assignments for the aldehyde
(2), as well as those for compounds (1 a) and (1 b), that correspond well with recently47
CHCL3
H
HO
H6,,
H6a
Hsa 1-13b Has
la X=H2OH
1 b X=D,OH
2 X=0
10.09.59.0 0.56.07.5 7.06.56.0 5.56.0.5.03.53.02.52.01.5 1.0 .5 0.0
Figure 2.2 1H nmr of compound (2).
Table 2.1 1H nmr chemical shifts in ppm (6).
iaa 1 b' 2b
2-H 5.63, sc 5.64, s 6.81, qd
3-H. 3.72, dte 3.73, ddf 4.78, br m9
3-Hb 3.29, dddh 3.29, dt 3.94, br m
5-H. 3.13, br m 3.14, br m 3.94, br m
5-Hb 2.60, br m 2.61, br m 3.14, br m
6-1-1..b 1.84, br m 1.85, br m 2.25, br. m
7-H 4.28, br m 4.29, br m 4.78, br m
8-H 4.12, br m 4.10, br m 5.15, di
9-1-1..b 4.12, br m 4.10, br m 9.80, s
'Taken in D20. bTaken in CDCI3.cs is singlet dq is quadruplet
edt is doublet triplet 'odd is doublet doublet
gbr m is broad multiplethddd is doublet doublet doubletid is doublet48
published nmr data (Wider et al., 1992). The overlap between protons 7-H and 3-Ha
and protons 3-Hb and 5-Ha in compound (2) prevented the coupling constants from
being determined.Further characterization of 2 was complicated by instability
under various conditions, including but not limited to, heat, silica gel, and storage
at greater than 0 °C.For compounds (la) and (lb), many of the signals were
insufficiently resolved to allow extraction of coupling constants, although the large
coupling between 3-Ha and 3-Hb was clearly visible (see Experimental section).
The reduction of aldehyde (2) closely followed earlier methods (Mattocks,
1982; Piper et al., 1981; Shumaker et al., 1978). We have, however, found that the
reduction can be readily performed in a Me0H-Et20 solvent mixture, avoiding
isolation and retarding decomposition of the rather unstable aldehyde (2).
Treatment of 2 with NaB2H4 affords C9-2H-retronecine in 71% overall yield (from la
to 1b). Figure 2.3 shows the proton nmr spectra for compounds (la) and (lb) in the
region affected by the deuterium substitution. The signal centered at 4.3 ppm is
due to 7-H, while the signal centered at 4.1 ppm is from the three protons 8-H and
9-H. The integration in the 3.9-4.2 ppm region clearly indicates the presence of
three protons in la, but only two protons in lb. The deuterium nmr of compound
(lb) consists of two singlets with equal integration.This occurs because the
reducing agent (NaB2H4) is not stereoselective and gives rise to both the R and S
configurations at C-9 in approximately equal amounts.
We anticipate using the deuterium labelled retronecine to investigate the
detoxification of pyrrolizidine alkaloids by sheep ruminal bacteria. Detection of the
deuterium label in the degradation products will allow us to determine the49
degradation pathway(s). The greater efficiency involved in labelling retronecine will
greatly facilitate our studies of the biological degradation of retronecine, and will
also facilitate other workers in this area.
43
la
42 4.1
PPM
4.0 43
Figure 2.3 11-1 nmr detail of compounds (la) and (lb).
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Chapter 3
A ROUTINE METHOD FOR THE DETERMINATION OF RETRONECINE
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ABSTRACT
A method for the routine determination of the necine base retronecine from
biological matrices is described, using gas chromatography for quantification. The
biological matrices studied included blended sheep whole rumen fluid and bacterial
growth media. The structurally similar compound 2,6-dimethoxypyridine was utilized
as an internal standard. Prior to gas chromatography, the bis(heptafluorobutyrate)
derivatives of both compounds were formed. The relative percent recoveries of
retronecine and the internal standard were 73% and 82%, respectively.The
detection limit of retronecine was found to be 0.09 pg/mL in blended whole rumen
fluid and 0.02 pg/mL in bacterial growth media. The precision of the peak area ratio
(retronecine to internal standard) was 10% from blended whole rumen fluid, and
14% from bacterial growth media. This method was used to analyze samples from
viable cultures incubated with retronecine.
INTRODUCTION
Over 300 unique pyrrolizidine alkaloids have
been isolated and identified from thousands of different
plant species, many of which are hepatotoxic to both
livestock and humans (Bull et al., 1968; Culvenor, 1980;
Logie et al.,1994; Mattocks, 1986).Pyrrolizidine
alkaloids consist of a necine base attached through one
or more ester linkages to a necic acid.The most
Figure 3.1 Structure of
retronecine.54
common necine base is retronecine (Figure 3.1), with approximately 40% of all
structurally elucidated pyrrolizidine alkaloids containing retronecine (Logie et al.,
1994). The parent alkaloids are non-toxic, but they are metabolized in the liver by
several pathways, some of which produce non-toxic metabolites (necic acid and
necine base or N-oxides) and some of which produce toxic metabolites (pyrrolic
compounds; Segall et al., 1991; Swick, 1984).
Cattle are particularly susceptible to pyrrolizidine alkaloid poisoning while
sheep and goats are quite resistant (Cheeke, 1984; Dollahite, 1972; Hooper, 1978;
Kingsbury, 1964). The resistance of sheep and goats to these toxins has been
attributed to bacterial metabolism within the rumen which detoxifies the pyrrolizidine
alkaloids before they are absorbed into the bloodstream and transported to the liver
(Craig et al., 1986, 1992; Dick et al., 1963; Lanigan, 1970). Work in Australia has
focused on sheep which are resistant to pyrrolizidine alkaloid poisoning by the
common plant Heliotropium europaeum. Rumen fluid from sheep exposed to H.
europaeum detoxifies pyrrolizidine alkaloids by cleaving the ester linkages and
saturating the ring system (Dick et al., 1963; Lanigan and Smith, 1970). No further
degradation of the necine base has been observed (Lanigan, 1970). Work in this
laboratory has focused on sheep which are resistant to pyrrolizidine alkaloid
poisoning by the common plant Seneciojacobaea (tansy ragwort). Tansy ragwort
contains several cyclic diester pyrrolizidine alkaloids which contain the necine base
retronecine (Bull et al., 1968; Mattocks, 1986). To aid in these metabolic studies,
it was necessary to determine retronecine from liquid culture media, in the pg/mL
range without significant interferences.55
Many of the studies on the liver metabolism of pyrrolizidine alkaloids include
assays for retronecine which are generally either preparative or qualitative in nature
(Dueker et al. 1992a; Eastman and Segall, 1982; Mattocks, 1981). There are
several studies which utilize 14C-labeled pyrrolizidine alkaloids in which products are
typically separated with semi-preparative HPLC. Individual fractions are then used
to qualitatively determine each product, and liquid scintillation counting is used to
quantitate the total amount of 14C-labeled products recovered (Dueker et al., 1992a,
1992b; Eastman and Segall, 1982).Hydrolysis rates are often determined by
quantitating remaining pyrrolizidine alkaloid and the necic acid produced, but not the
necine base (Chu and Segall, 1991; Dueker et al., 1992b). None of these methods
are quantitative or have low enough detection limits to be applicable to our
metabolic studies. Only recently, has a quantitative assay for retronecine from
microsomal studies been described (Dueker et al., 1995), but it does not utilize an
internal standard and is not optimized for sheep whole rumen fluid. The method
presented here has been optimized for sheep whole rumen fluid and 2,6-
dimethoxypyridine was selected as an appropriate internal standard.This
compound is structurally similar to retronecine, and has similar reactivity under the
selected conditions. The bis(heptafluorobutyrate) derivatives of both compounds
were formed and analyzed by gas chromatography.56
EXPERIMENTAL
Chemicals
All solvents were HPLC grade or better and were purchased from commercial
sources. Type I reagent grade filtered water was produced in a Milli-Q water system
(Millipore, Bedford, MA). The derivatization reagents and the compounds listed in
Tables 3.1 and 3.2 were purchased from commercial sources. Retronecine was
isolated and purified as previously described (Hovermale et al., 1994).Stock
solutions of retronecine were prepared at a concentration of 10 mg/mL in either
methanol or phosphate buffer (pH=7) and diluted as necessary into water, basal
growth media or blended whole rumen fluid.The basal growth media was a
modification of MPN-PA medium; modifications included the omission of hemin and
volatile fatty acids except for sodium acetate and the addition of sodium formate
(5.0 g/L), tryptone (1.0 g/L) and yeast extract (2.0 g/L) (Wachenheim et al., 1992).
Sheep whole rumen fluid was blended with a modification of McDougall buffer
(25:75) (McDougall, 1948; Wachenheim et al., 1992). Working standards were
prepared in both basal growth media and blended whole rumen fluid and ranged
from 0 to 100 pg/mL. Stock solutions of 2,6-dimethoxypyridine (internal standard)
were prepared at a concentration of 10 mg/mL in methanol. The working internal
standard solution was prepared daily by diluting to 1 mg/mL in water.57
Table 3.1 Compounds tested as possible internal standards with two
derivatization reagents, HFBI and HFBA, which did form derivatives.
Name Derivatization
Reagent
Number of Peaks
Observed
(retention time, min)
Comments
(about peaks)
4-acetamidophenol HFBI 1 (9.90) very small
HFBA 3 (9.74, 10.02, 10.03)
4-aminophenol hydrochloride HFBI 2 (9.86, 11.20) very small
HFBA 1 (9.76)
1,3-benzenediol HFBI 0
HFBA 1 (6.85) small
2- t- butyl -1,4- dihydroxybenzene HFBI 2 (11.45, 12.39) very small
HFBA 3 (9.05, 10.97, 11.10) double peaks
2,3-diaminotoluene HFBI 1 (11.51) very small
HFBA 1 (11.35) very small
2,6-dimethoxypyridine HFBI 1 (9.82)
HFBA 1 (9.81)
3-pyrrolidino-1,2-propanediol HFBI 1 (8.52) small
HFBA 0
1,4-dihydroxy-2,3,5- HFBI 3 (9.51, 11.27, 11.96) very small
trimethylbenzene
HFBA 2 (9.44, 11.37) small
Table 3.2 List of compounds tested as possible internal standards which did not
form derivatives with either derivatization reagent, HFBI or HFBA.
2,6- di- t- butyl -4- methylphenol
2,4-diaminophenol dihydrochloride
2,4-diaminotoluene
2,6-diaminotoluene
3,4-diaminotoluene
2,3-dihydroxypyridine
2-methoxypyridine
phenol58
Sample Preparation
Experimental samples were typically analyzed in duplicate 1-mL aliquots.
Optimization studies typically utilized 1-mL aliquots of water, basal growth media,
or blended whole rumen fluid spiked with retronecine (100 pg/mL). To each, a glass
bead and 100 pL of the working internal standard solution were added and
vortexed. Samples were dried under the flow of nitrogen, with heat applied (70 °C)
and with vortexing of the samples half way through the drying process.After
acetonitrile had been added (2 mL), the samples were vortexed and sonicated to
dissolveand/orsuspendresidue. Thederivatizationreagent
heptafluorobutyrylimidazole (HFBI) was added (300 pL), and the samples vortexed
and heated at 70 °C for 15 min in a block heater. The samples were centrifuged
at 1520 RCF for 5 min, and the supernatant was then analyzed.
Samples for analysis by GC/MS were prepared in a manner similar to that
described herein except for the following modifications. Internal standard was not
always added, and toluene was used in place of acetonitrile. To remove excess
derivatization reagent after heating, 1 mL of water was added and the samples were
vortexed and centrifuged. The organic layer was then analyzed.
Instrumentation
Gas chromatography was performed on an Rt,(-5 capillary column (30-m x
0.25-mm, 0.25-pm film thickness, Restek Corp., Bellefonte, PA) using a Perkin-
Elmer Autosystem gas chromatograph (Perkin-Elmer Corp., Norwalk, CT) equipped59
with a flame ionization detector and a split-splitless injector operated in the splitless
mode (injector temp. 200 °C, detector temp. 350 °C, temp.program: 60 °C (1 min),
25 °C/min to 150 °C (6 min), 25 °C/min to 250 °C (2 min)). Heliumwas used as the
carrier gas. Data were collected at a rate of 3.448 points/s usingan PE Nelson 970
interface box and Turbochrom chromatography software runningon a personal
computer (Perkin-Elmer Corp., PE Nelson Div., San Jose, CA).
Gas chromatography-mass spectrometry (GC/MS) using electron ionization
(El, 70 eV) was performed on either a Finnigan GC (Finnigan Corp., Austin, TX)or
a HP model 5890 GC (Hewlett-Packard Co., Palo Alto, CA) interfaced with a
Finnigan 5100 quadrupole mass spectrometer. Chromatographic conditionswere
as described above. Samples were injected by a HP model 7673A automatic
injector.The transfer line and manifold were held at 250 °C and 100 °C,
respectively. The scan range was 45-620 amu (1.15 s/scan). Datawere collected
via personal computer running Galaxy 2000 software (LGC, San Jose, CA).
RESULTS AND DISCUSSION
Analytical procedure
Samples must be completely dry upon the addition of the HFBI,as water
destroys the derivatization reagent. Samples of blended wholerumen fluid are
sometimes resistant to drying by the formation of a thin skinon the surface which
can trap small amounts of water beneath it. The addition of the glass bead and60
vortexing once during the drying step provides the opportunity for the surface skin
to be broken so that samples dry completely and homogeneously.
A typical chromatogram of retronecine prepared from blended wholerumen
fluid illustrates that excess derivatization reagent and by-products elute in three
different areas (Figure 3.2). The two large fronted peaksvary in size and exact
retention time with individual samples, with the two peaks of interest eluting after all
excess derivatization reagent and by-products. Occasionally in samples with little
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Figure 3.2 GC/FID chromatogram of retronecine (100 pg/mL) prepared from 1
mL of blended whole rumen fluid. A) Entire chromatogram showing the solvent
peak (1) and excess derivatization reagent and by-products (2). B) Expanded
view in the region of the analyte showing the bis(heptafluorobutyrate) derivative
of 2,6-dimethoxypyridine (3) and the bis(heptafluorobutyrate) of retronecine (4).
GC temp. program: 60 °C (1 min), 25 °C/min to 150 °C (6 min), 25 °C/min to
250 °C (2 min). Injector temp. 200 °C, detector temp. 350 °C.61
or no retronecine, excess reagent results in an elevated baseline in the region of the
analyte and the internal standard.
Selected samples were analyzed by GC/MS to confirm peak identity. The
mass spectrum for the bis(heptafluorobutyrate) derivative of retronecine (Figure
3.3A) is consistent with those published for this compound (Deinzer et al., 1978).
The bis(heptafluorobutyrate) derivative of the internal standard was also confirmed
by GC/MS (Figure 3.3B).
Influence of derivatization reagent
Five derivatization reagents which would acylate polar groups such as
hydroxyls and amines were investigated, and HFBI was found to be the best choice.
The other derivatization reagents were trifluoroacetic acid anhydride (TFAA), N-
trifluoroacetylimidazole (TFAI), acetic acid anhydride (AAA) and heptafluorobutyric
acid anhydride (HFBA). The matrix of most interest in these experiments, whole
rumen fluid,is a complicated matrix containing many potentially interfering
compounds, as well as particulate matter.Experiments testing the different
derivatization reagents generally followed the sample preparation method described
in the experimental. Variations included using toluene and/or acetonitrile, lower
temperatures during heating, or longer heating times.In order to reduce the
number of steps and potential loss of analyte, excess derivatization reagent was not
removed from the samples except in the case of AAA.
Under none of the conditions tested were any derivatives formed when using
AAA as the derivatization reagent. The bis(trifluoroacetate) derivative was formed62
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Figure 3.3 Mass spectra of derivatives. A) Bis(heptafluorobutyrate)
derivative of retronecine. MW 547. B) Bis(heptafluorobutyrate) derivative
of 2,6-dimethoxypyridine. MW 531.63
by both TFAA and TFAI, with confirmation by GC/MS. In samples of blankrumen
fluid prepared with TFAI, a small peak was present at 8.24 min which coeluted with
the bis(trifluoroacetate) derivative of retronecine which eluted at 8.28 min. The
bis(heptafluorobutyrate) derivative of retronecine, being a higher molecular weight
compound, eluted later at 9.11 min, and did not interfere with any peakseen in
blank rumen fluid. HFBI was chosen as the optimum derivatization reagent, and
excess HFBI and byproducts are observed in the typical chromatograms.
Choice of internal standard
Numerous different compounds were tested as possible internal standards
with two derivatization reagents, HFBI and HFBA. Compounds which formed
derivatives are included in Table 3.1, and compounds which did not form derivatives
are listed in Table 3.2. All of the chosen compounds had at least one of the key
structural characteristics of retronecine (heterocyclic ring system, amine, hydroxyl
groups, double bond). Experiments testing the different potential internal standards
generally followed the sample preparation method described in the experimental.
Variations included using less derivatization reagent, no heating, or longer heating
times.
Several factors led to the decision that the most suitable internal standard
would be 2,6-dimethoxypyridine. When reacting with the imidazole, the 2,6-
dimethoxypyridine yielded one clean peak that eluted near retronecine, but did not
overlap with it, or any of the peaks normally present in blended wholerumen fluid.
At a concentration of 100 pg/mL, 2,6-dimethoxypyridine yieldsa peak nearly64
equivalent in area to that of retronecine at this concentration.It contains several of
the key structural elements in retronecine, including two derivatizable hydroxyl
groups and a tertiary amine within a heterocyclic ring system.Also, both
compounds have at least one hydroxymethyl group which is adjacent to a double
bond. GC/MS confirmed the structure of the bis(heptafluorobutyrate) derivative of
2 ,6-d imethoxypyrid ine.
Different solvents
Several different solvents were studied in addition to acetonitrile, including
acetone, ethyl acetate, dioxane, pyridine, dimethyl formamide (DMF) and dimethyl
sulfoxide (DMSO). Experiments testing the different solvents generally followed the
sample preparation method described in the experimental. Variations included less
derivatization reagent, longer and shorter heating times, smaller samples, and less
solvent. The solvents ethyl acetate and acetonitrile both yielded large, well shaped
peaks for both compounds. As many of the initial experiments had been conducted
with acetonitrile, it was decided to continue using acetonitrile to maintain continuity.
Heating time
With 0.5 mL acetonitrile and 200 pL of HFBI, the influence of no heating
(ambient temperature) and heating at 70 °C for 15-120 min was investigated.
Heating increased the peak areas, but heating longer than 15 min did not yield
significantly larger peak areas.65
Solvent and derivatization reagent volume
A series of experiments was run to determine the optimum volume of both
acetonitrile and HFBI. The volume of acetonitrile varied from 1-3 mL and the
volume of HFBI varied from 200-500 pL. Shown in Table 3.3 are the peak areas of
retronecine and the internal standard when prepared from 1 mL samples of spiked
blended rumen fluid. As whole rumen fluid is a complex matrix that may contain
other compounds with derivatizable groups, it was anticipated that an excess of
HFBI might be required.
Increasing the volume of acetonitrile typically resulted in smaller peak areas
due to sample dilution. However, when increasing the volume of acetonitrile from
1 to 2 mL, the peak areas would be expected to decrease about 50%; the data in
Table 3.3 shows that with 300 pL of HFBI or greater, peak area decreases only 10
20%. This indicates that increasing the acetonitrile volume enhances the reaction
and yields a greater amount of product. When using 2 mL of acetonitrile, increasing
the HFBI volume from 200 to 300 pL results in larger peak areas, but above 300 pL
of HFBI the peak areas appear to stabilize. At the higher volumes of HFBI, excess
derivatization reagent and by-products become larger and sometimes interfere with
the peaks of interest. Thus it was determined that using 2 mL of acetonitrile and
300 pL of HFBI is an acceptable compromise between dilution and product
formation.66
Table 3.3 Peak areas of retronecine (ret) and the internal standard (int std) when
prepared with varying volumes of acetonitrile (ACN) and HFBI.
ACN vol (mL):
peak area: ret
1 2 3
int std ret int std ret int std
HFBI vol (4)
200 194,510178,469105,354 104,882
300 141,100126,167114,516 115,45994,79095,028
400 124,520 111,285 81,13281,846
500 122,181 112,88883,11283,792
GC conditions identical to those in Figure 3.2, except the injector temp. was 180 °C.
Quantification
Quantification of retronecine in samples was based on a least squares fit of
the peak area ratio of the analyte to internal standard versus analyte concentration.
The working standards in both basal growth media and blended whole rumen fluid
were prepared and chromatographed as described previously. A typical equation
for the linear regression of working standards in blended whole rumen fluid is as
follows: y = 8.74 x 10-3(x) + 1.47 x 10-3.
Detection limit
The detection limit, calculated from a 1 pg/mL sample of retronecine in water,
was determined to be 0.02 pg/mL (1.7-s peak width at half height); the detection67
limit, calculated from a 5 pg/mL sample of retronecine in blended wholerumen fluid,
was determined to be 0.09 pg/mL (2.0-s peak width at half height).
Methods for determining the detection limit of a method utilizingan internal
standard are not well described. These detection limits were calculated using
2Nw/AR, where N is the noise in the peak area ratio, w is the sample weight, and AR
is the peak area ratio (Poole and Schuette, 1984). The noise in the peakarea ratio
(N) was calculated using (N/AR)2 = (si/A1)2 + (s2/A2)2 which is derived using
propagation of error techniques (Shoemaker et al., 1989). The variables Al and A2
are the peak areas of retronecine and the internal standard, respectively, and si and
s2 are the estimates of the standard deviations of the peak areas of retronecine and
the internal standard, respectively.As the detection limit is approached, Al
approaches zero while A2 remains relatively constant. Thus (si/A1)2 becomes very
large compared to (s2/A2)2, and N can be approximated by N = s, /A2. As the
detection limit is approached, the standard deviation of the mean of the total area
of retronecine approaches the standard deviation of the mean of the baseline, thus
sl can be estimated using si = (shin)12, where s is the standard deviation in the
baseline and n is the number of data points used to determine the peakarea.
Recovery
The relative percent recoveries of retronecine and the internal standardwere
73% and 82%, respectively (n = 20). The relative percent recovery was calculated
from the ratio of each component's peak area in blended wholerumen fluid to its
peak area in water.Replicate samples (1 mL each) were prepared and68
chromatographed as described previously.Corrections based on the relative
recovery were not used when quantitating samples.
Precision
The relative standard deviations of the peak areas of retronecine and the
internal standard prepared from water (1 mL each) were 7% and 15%, respectively.
The corresponding RSD of the peak area ratio was 14% (n = 20). The RSD of the
peak areas of retronecine and the internal standard prepared from blended whole
rumen fluid (1 mL each) were 10% and 12%, respectively. The corresponding RSD
of the peak area ratio was 10% (n = 20). The RSD of the peak area ratio from
blended whole rumen fluid of 10% was considered acceptable for quantitation.
Analysis of Incubation Samples
Retronecine was incubated with cultures inoculated with either blended
sheep whole rumen fluid or a pyrrolizidine alkaloid degrading enrichment (L4M2).
Duplicate bottles contained retronecine at initial levels of 50-100 pg/mL. Samples
were taken and frozen from all bottles at time zero, and throughout the incubation
period (2 days or 2 weeks). Samples (1 mL each) were prepared and analyzed in
duplicate as described previously. The results of the analysis for retronecine are
shown in Figure 3.4. In both cases the concentration of retronecine did not change
appreciably over the incubation period. Over the 48-hr incubation period, the RSD
of the concentration of retronecine in the blended sheep whole rumen fluid in120
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Figure 3.4 Results of retronecine analysis. Duplicate bottles individual data
points(lb, A)and the linear regression ( ). A) Blended sheep
whole rumen fluid incubated for two days. B) Basal media inoculated with L4M2
and incubated for two weeks.70
duplicate bottles was 13% and 9%; this is not significantly different than the RSD
of the method determined in blended whole rumen fluid which is 10%. The slopes
of the linear regressions through the individual data pointswere -0.38 and -0.33
pg/mUhr. Over the 2-week incubation period, the RSD of the concentration of
retronecine in the basal growth media in duplicate bottles was 3% and 2%; this is
significantly less than the RSD of the method determined in water which is 14%.
The slopes of the linear regressions through the individual data pointswere -0.27
and -0.07 pg/mUday. Under these conditions, retronecinewas not degraded by
sheep whole rumen fluid or by the enrichment L4M2.
CONCLUSIONS
This method enables the determination of retronecine from biological
matrices on a routine basis. The technique has been developed specifically for
liquid culture media with regard to decreasing sample preparation time and
complexity, and increasing reproducibility. This method is currently being used to
investigate the detoxification by sheep ruminal bacteria of pyrrolizidine alkaloids
isolated from tansy ragwort.Studies are being conducted with both blended whole
rumen fluid and the bacterial enrichment L4M2. The ability to detect retronecine
from these biological matrices at low levels will aid in determining if hydrolysis
contributes significantly to the detoxification of pyrrolizidine alkaloids by ruminal
microbes. Using this analytical method, the experiments presented in Chapter 4
indicate that hydrolysis is not occurring within the rumen.71
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Chapter 4
METABOLISM OF RETRONECINE AND PYRROLIZIDINE ALKALOIDS BY
OVINE RUMINAL BACTERIA
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ABSTRACT
Macrocyclic pyrrolizidine alkaloids are produced naturally by Senecio
jacobaea which are toxic to several species of livestock, including cattle and horses.
Sheep, however, typically display resistance to pyrrolizidine alkaloid poisoning. This
resistance to pyrrolizidine alkaloid toxicosis has been attributed to metabolism of
pyrrolizidine alkaloids within the rumen by anaerobic microbes. In this study the
metabolism of pyrrolizidine alkaloids by ovine ruminal microbeswas investigated
with the specific focus being the potential intermediate retronecine, a non-esterified
necine base.Metabolism of retronecine independent of the macrocyclic
pyrrolizidine alkaloids was also investigated. Experiments were conducted with both
blended ovine whole rumen fluid and with a mixed culture of pyrrolizidine alkaloid-
metabolizing microbes derived from ovine rumen fluid.Retronecine was not
observed as a transient intermediate under these conditions, and also it was not
metabolized independent of the macrocyclic pyrrolizidine alkaloids.
INTRODUCTION
Pyrrolizidine alkaloids are produced in numerous plants throughout the world.
Many of the isolated and identified pyrrolizidine alkaloids (over 300) are toxic to
several species, including cattle, horses, rats, and humans (Culvenor, 1980;
Mattocks, 1986; Segall et al., 1991). Other species, such as sheep and goats, have
demonstrated resistance to pyrrolizidine alkaloid toxicosis. In fact, sheepare used
as biological control agents in areas heavily infested with pyrrolizidine alkaloid75
containing plants (Cheeke, 1984; Dollahite, 1972; Hooper, 1978).In the Pacific
Northwestern region of the United States, tansy ragwort (Senecio jacobaea) isa
pyrrolizidine alkaloid containing plant of economic importance. Tansy ragwort
contains several macrocyclic pyrrolizidine alkaloids which cause irreversible liver
cirrhosis in cattle, while sheep are typically not affected.It has been demonstrated
that metabolism of the pyrrolizidine alkaloids in tansy ragwort by anaerobic ruminal
microorganisms is responsible for protecting sheep from toxicosis (Craig et al.,
1986, 1992; Wachenheim et al., 1992a, 1992b).
All of the pyrrolizidine alkaloids in tansy ragwort are macrocyclic diesters of
the necine base retronecine (Mattocks, 1986), with the two most abundant
pyrrolizidine alkaloids being jacobine and seneciphylline (Figure 4.1). The parent
alkaloids are non-toxic, but once they are absorbed into the bloodstream and
transported to the liver they can be converted by the mixed function oxidase
systems to toxic pyrroles (Mattocks and White, 1971; Segall et al., 1991). The
pyrroles then bind to proteins and macromolecules causing liver lesions and
HO HO
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Figure 4.1 Structures of the two most predominant pyrrolizidine alkaloids in
tansy ragwort, seneciphylline and jacobine, and the necine base retronecine.76
ultimately cirrhosis (Cheeke and Shull, 1985; Hsu et al., 1975; Kim et al., 1995;
Swick 1984; White and Mattocks, 1972). Hydrolysis of pyrrolizidine alkaloids in the
rumen would result in the necine base retronecine, a product consistent with the
lack of toxicological effects observed in sheep.If retronecine is produced in the
rumen it would be absorbed and transported to the liver, but since the mixed
function oxidase systems show very little activity towards retronecine, it would not
be converted to toxic pyrroles but instead excreted in the urine (Mattocks, 1978,
1981).
Recent work in this laboratory has been aimed at determining the ruminal
metabolic pathway. To this end, our laboratory has utilized an anaerobic mixed
culture derived from ovine rumen fluid (identified as L4M2) which metabolizes the
pyrrolizidine alkaloids isolated from tansy ragwort. It is likely that this mixed culture
contains anywhere from three to six microbes, each of which may play a part in the
pyrrolizidine alkaloid metabolism. One or more organisms could be hydrolyzing the
pyrrolizidine alkaloids to the necic acid and the necine base retronecine; however,
preliminary work with this culture has indicated that metabolites containinga necine
base ring system are not being produced. It is possible that other organisms in the
mixed culture could be further metabolizing retronecine.If this is the case,
retronecine may be observed only as a transient intermediate during the metabolism
of pyrrolizidine alkaloids, but also retronecine itself should also be metabolized,
independent of the macrocyclic pyrrolizidine alkaloids.
This study has two main objectives: 1) to determine if retronecine is produced
during the metabolism of the pyrrolizidine alkaloids isolated from tansy ragwort,77
either as an end-product or as a transient intermediate; 2) to determine if
retronecine is degraded independently of the macrocyclic pyrrolizidine alkaloids.
These experiments utilized both ovine whole rumen fluid and the mixed culture,
L4M2. Based on previously defined methods (Craig et al., 1992; Wachenheim et
al., 1992a), pyrrolizidine alkaloids isolated from tansy ragwort were metabolized by
sheep ruminal microbes, and the presence or absence of retronecine was
determined at intermediate time points. Also, attempts were made to metabolize
retronecine directly with sheep ruminal microbes, both alone and in combination
with the pyrrolizidine alkaloids isolated from tansy ragwort.
MATERIALS AND METHODS
Media and growth conditions
Rumen contents were obtained from rumen-cannulated sheep 2-4 hr after
feeding and transported anaerobically to the laboratory. All subsequent procedures
were performed anaerobically.The ruminal contents were blended with a
modification of McDougall Buffer (25:75) at high speed for 1 min, then dispensed
into serum bottles (100 mL in 200-mL serum bottles), and stock solutions (10
mg/mL) of either pyrrolizidine alkaloids isolated from Senecio jacobaea and/or
retronecine were added for a final concentration of 50-100 pg/mL. The stock
solutions were prepared in 1% phosphoric acid adjusted to pH 7.0 with sodium
hydroxide. The bottles were incubated at 37 °C with shaking, and sample aliquots
were removed at appropriate time intervals and frozen until analysis. Incubations78
were performed in duplicate or triplicate. Autoclaved serum bottles served as sterile
controls, and serum bottles without pyrrolizidine alkaloids or retronecine added
served as viable controls.
The mixed culture L4M2 which metabolizes the pyrrolizidine alkaloids in
Senecio jacobaea has been derived from ovine rumen fluid in this laboratory
(Johnston, 1995). L4M2 was grown in a basal growth media which is a modification
of previously defined MPN-PA medium; modifications included the omission of
hemin and volatile fatty acids except for sodium acetate and the addition of sodium
formate (5.0 g/L), tryptone (1.0 g/L) and yeast extract (2.0 g/L) (Wachenheim et al.,
1992a). Stock solutions of pyrrolizidine alkaloids or retronecine were added as
described above to cultures inoculated with the L4M2 culture on the previous day.
The bottles were incubated at 37 °C with shaking, and sample aliquots were
removed at appropriate time intervals and frozen until analysis. Incubations were
performed in duplicate. Uninoculated serum bottles served as sterile controls, and
serum bottles without pyrrolizidine alkaloids or retronecine served as viable controls.
Pyrrolizidine Alkaloid Analysis
Pyrrolizidine alkaloids were determined by TLC analysis (Wachenheim et al.,
1992a). Samples (1 mL) were mixed with 5 M NaOH (100 pL) and dichloromethane
(500 pL). Samples were centrifuged for 5-15 min as necessary to separate the
layers. The dichloromethane was transferred to a clean glass tube (12x75 mm) and
then removed under vacuum at 43 °C.Residue was reconstituted in 20 pL of
dichloromethane and spotted on HPKF silica gel TLC plates (Whatman, Clifton, NJ).79
Chromatograms were developed in a chloroform-methanol-propionicacid (36:9:5)
solvent. Visualization of alkaloids was by sequential sprayingwith Dragendorff
spray reagent (Sigma Co., St. Louis, MO) and 5% sodium nitrite. The Rf values of
jacobine (reddish brown), seneciphylline (dark purple) andsenecionine (orange)
were 0.66, 0.72 and 0.76, respectively. The detection limit of total pyrrolizidine
alkaloids was estimated to be 2 pg/mL (basedon visual detection), although distinct
colors were only visible down to 6 pg/mL.
Retronecine Analysis
A recently developed method for the determination of retronecinewas utilized
with subsequent GC/FID or GC/MS analysis (Hovermale and Craig, 1998;Chapter
3). Briefly, 2,6-dimethoxypyridine was added to duplicate aliquots (1 mL) of each
sample and then dried (70 °C). The bis(heptafluorobutyrate) derivativeswere
formed using N-heptafluorobutyrylimidazole in acetonitrile (70 °C, 15 min). The
supematant could by analyzed directly by GC/FID. Samples prepared for analysis
by GC/MS were prepared using toluene in place of acetonitrile, andexcess
derivatization reagent was removed before analysis. Chromatography conditions
were as previously described (Hovermale and Craig, 1998). The detection limitwas
reported to be 0.09 pg/mL in blended whole rumen fluid and 0.02 pg/mL in basal
growth media.80
RESULTS
Metabolism by blended ovine whole rumen fluid
In the cultures of viable whole rumen fluid in which pyrrolizidine alkaloids
were added without retronecine, the pyrrolizidine alkaloids were metabolized to
undetectable levels in less than 24 hr; whereas, in the autoclaved controls, the
pyrrolizidine alkaloids were present throughout the 48-hr incubation period. This is
consistent with previously published results for pyrrolizidine alkaloid metabolism
(Craig et al., 1992; Wachenheim et al., 1992a). Retronecine was not detected from
any of these cultures throughout the 48-hr incubation period. Controls which had
no pyrrolizidine alkaloids added (both viable and sterile) had none present at any
of the time points tested. Under these conditions retronecine was not detected as
an intermediate during pyrrolizidine alkaloid metabolism.
In the cultures of viable whole rumen fluid in which only retronecine was
added, the concentration of retronecine did not change appreciably over the 48-hr
incubation period (presented in part, Hovermale and Craig, 1998). In the cultures
of viable whole rumen fluid in which pyrrolizidine alkaloids and retronecine were
both added, the macrocyclic pyrrolizidinealkaloids were metabolized to
undetectable levels in less than 24 hr, and the concentration of retronecine did not
change appreciably over the 48-hr incubation period (Figure 4.2). The relative
standard deviation (RSD) for determining the concentration of retronecine at 100
pg/mL was previously determined to be 10% (Hovermale and Craig, 1998; Chapter
3); over the 48-hr incubation period, the RSD of the concentration of retronecine in81
triplicate bottles was found to be 6%, 13% and 10%.The slopes of the linear
regressions through the individual data points (Figure 4.2) were -0.10, -0.37, and
-0.52 pg/mUhr. In sterile controls in which retronecine was added, either with or
without pyrrolizidine alkaloids, the concentration of retronecine also did not change
appreciably over the 48-hr incubation period (RSD = 6%, slope = 0.05 pg/mUhr).
Under these conditions retronecine was not degraded by the ovine whole rumen
fluid.
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Figure 4.2 Results of retronecine analysis from incubation bottles of blended
sheep whole rumen fluid initially containing both retronecine and macrocyclic
pyrrolizidine alkaloids. Triplicate bottles individual data points (, , A) and
the linear regression (, ).82
Metabolism by the mixed culture L4M2
In the cultures of viable L4M2 in which pyrrolizidine alkaloids were added, the
pyrrolizidine alkaloids were metabolized to undetectable levels in less than 7 days;
whereas, in the uninoculated control, the pyrrolizidine alkaloids were present
throughout the 2-week incubation period. In these cultures (both viable and sterile),
retronecine was not detected for the first 4 days of incubation, but for the samples
after 7, 10 and 13 days of incubation, very low levels of retronecine were detected
(less than 5 pg/mL, compared to 100 pg/mL of pyrrolizidine alkaloids initially added).
The presence of retronecine in these samples was confirmed by GC/MS analysis.
The exact source of this retronecine is unclear, but because it appears in both
viable and sterile cultures, it is likely that the source is not due to microbial
metabolism.
For controls to which no macrocyclic pyrrolizidine alkaloids were added (both
viable and sterile), none were detected in any of the samples tested. Also for the
cultures to which retronecine was added, no pyrrolizidine alkaloids were detected
in any of the samples tested. Under these conditions, a significant amount of
retronecine above the sterile control was not detected as an intermediate during
pyrrolizidine alkaloid metabolism.
In the cultures of viable L4M2 to which retronecine was added, the
concentration did not change appreciably over the 2-week incubation period
(presented in part, Hovermale and Craig, 1998).In the controls to which no
retronecine or pyrrolizidine alkaloids were added (both viable and sterile), no83
retronecine was detected throughout the 2-week incubation period. Underthese
conditions retronecine was not degraded by the mixed culture L4M2.
DISCUSSION
The mean retention time of material in the gut of sheep has been reported
to be 47.4 ± 26.5 hr (Stevens, 1988). Turnover times forrumen particulate matter
in sheep ranges from 19 to 53 hr, with most values being slightlyover 24 hr
(Dehority, 1997). For ruminal metabolism to be beneficial to the sheep, it must
occur within this time period. To account for possible animal to animal variation,
these experiments with blended whole ovine rumen fluid were all conducted for 48
hr. Metabolism of pyrrolizidine alkaloids by blended ovine wholerumen fluid was
observed to occur is less than 24 hr, consistent with previous work (Craig et al,
1992; Wachenheim et al., 1992a).If hydrolysis of the pyrrolizidine alkaloids was
occurring, then the concentration of retronecine should increase within 24 hr, after
which time its concentration should either stabilize if it is not further metabolized,or
decrease if it is further metabolized. This is based on the assumption that the
hydrolysis of macrocyclic pyrrolizidine alkaloids occurs at about thesame rate or
significantly faster than that of retronecine.If the metabolism of retronecine is
significantly faster than that of the macrocyclic pyrrolizidine alkaloids, then
retronecine may not be detected as a transient intermediate. After comparing the
RSD of the retronecine concentrations in the blended wholerumen fluid to that
previously determined for the method it was determined that the concentration of
retronecine did not change significantly over the 48-hr incubation period.In the84
cultures of blended ovine whole rumen fluid with only retronecine added,again the
concentration of retronecine did not change significantlyover the 48-hr incubation
period.
In these studies with the mixed culture L4M2, 7 dayswere required to
metabolize pyrrolizidine alkaloids. Very low levels of retronecinewere observed in
these cultures, but because it was not greater than that in the sterile controls,it is
most likely not due to microbial metabolism.In the cultures of L4M2 with only
retronecine added, its concentration did not change significantlyover the 2-week
incubation period.The fact that L4M2 requires a longer time to metabolize the
macrocyclic pyrrolizidine alkaloids than blended whole ovinerumen fluid indicates
that ideal conditions simulating the rumen environment have not yet been achieved.
Growth conditions are currently being improved and will greatly facilitate further
studies.
Two main results suggest that hydrolysis of macrocyclic pyrrolizidine
alkaloids is not occurring within the sheep rumen.First, retronecine was not
observed to appear as an end-product when macrocyclic pyrrolizidine alkaloids
were metabolized. Second, retronecine was not metabolized independently of the
macrocyclic pyrrolizidine alkaloids. The metabolism of pyrrolizidine alkaloids in the
rumen which protects sheep from their toxicity must involve other reaction
pathways. Further studies are focused on identifying the metabolites containing the
necine base portion of the pyrrolizidine alkaloids. Because toxicity in the liver is
directly related to the conversion of the necine base toa pyrrole, it is likely that
detoxification mechanisms in the rumen modify this moiety of the molecule.85
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METABOLISM OF PYRROLIZIDINE ALKALOIDS BY
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ABSTRACT
A mixed culture of ovine ruminal microbes metabolizes the macrocyclic
pyrrolizidine alkaloids present in the plant Senecio jacobaea, including jacobine and
seneciphylline. Previous attempts to identify metabolites of these alkaloids have not
been successful. The objective of this study was to compare the metabolism of
pyrrolizidine alkaloids by the mixed culture of ovine ruminal microbes to the
metabolism of pyrrolizidine alkaloids by the known organism Peptostreptococcus
heliotrinreducens.P. heliotrinreducens metabolizes the pyrrolizidine alkaloids
heliotrine and lasiocarpine to 7a-hydroxy-1-methylene-8a-pyrrolizidine and 7a-
angely1-1-methylene-8a-pyrrolizidine,respectively.This organism does not
metabolize the pyrrolizidine alkaloids jacobine or seneciphylline. The mixed culture
of ovine ruminal microbes also metabolizes heliotrine and lasiocarpine to identical
methylene compounds.This mixed culture also metabolizes jacobine and
seneciphylline, with production of very low levels of the corresponding 1-methylene
compounds. Samples were analyzed with TLC and GC/MS.
INTRODUCTION
Sheep in the Pacific Northwestern United States are considered to be
resistant to pyrrolizidine alkaloid poisoning, especially by the plant Senecio
jacobaea (tansy ragwort) (Dollahite, 1972; Hooper, 1978; Muth, 1968). All of the
pyrrolizidine alkaloids in tansy ragwort are macrocyclic diesters of the necine base
retronecine, with the two most abundant being jacobine and seneciphylline89
(Mattocks, 1986). It has been demonstrated that the pyrrolizidine alkaloids in tansy
ragwort are metabolized in ovine ruminal fluid (Craig et al., 1992; Wachenheim et
al.,1992).A mixed culture of anaerobic microbes which metabolizes the
pyrrolizidine alkaloids jacobine and seneciphylline has been derived from the rumen
fluid of sheep maintained on tansy ragwort. This mixed culture has been named
L4M2 and contains anywhere from three to six microbes. It has not been possible
to isolate a pure culture which metabolizes jacobine or seneciphylline.
Previous attempts to conclusively identify metabolites produced by the
ruminal metabolism of jacobine and seneciphylline have been unsuccessful
(Hovermale and Craig, 1998; Chapter 3; Chapter 4). Most pyrrolizidine alkaloids are
not available commercially and must be isolated from plant material.Labelled
pyrrolizidine alkaloids are even more difficult obtain, with the most efficient method
being to grow pyrrolizidine alkaloid producing plants in an atmosphere of14CO2 or
by using some other labelled precursors (Lame et al., 1996; Reed et al., 1985).
This requires a considerable amount of time and specialized knowledge and
equipment. Generally yields are less than 2% recovery of label into the desired
compounds (Reed et al., 1985).Thus, using labelled compounds to identify
metabolic products was not considered a viable option.
In this study the metabolism of various pyrrolizidine alkaloids by L4M2 was
compared to the metabolism of these pyrrolizidine alkaloids by the organism
Peptostreptococcus heliotrinreducens. P. heliotrinreducens was originally isolated
from Australian sheep rumen contents and is known to metabolize several mono-
and diester pyrrolizidine alkaloids to compounds with a 1-methylene group external
to the pyrrolizidine ring (Figure 5.1) (Lanigan, 1976).P. heliotrinreducens90
metabolizes a few macrocyclic pyrrolizidine alkaloids more slowly than it does the
mono- and diesters; some macrocyclic pyrrolizidine alkaloids are not metabolized
at all (Lanigan, 1976).In this study, both P. heliotrinreducens and L4M2 were
grown on heliotrine, lasiocarpine, monocrotaline and a mixture of pyrrolizidine
alkaloids isolated from tansy ragwort. Samples from the cultures were analyzed for
pyrrolizidine alkaloids and methylene products using TLC and GC/MS.
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Figure 5.1 Pyrrolizidine alkaloids metabolized by Peptostreptococcus
heliotrinreducens to 1-methylene compounds.91
MATERIALS AND METHODS
Organism, media and growth conditions
Peptostreptococcus heliotrinreducens was purchased from the American
Type Culture Collection (Strain #29202) and grown in TYM medium in batch tubes
under anaerobic conditions at 38 °C (Lanigan, 1976). Cultures were maintained by
serial transfers on a daily basis.Parallel cultures were grown with different
pyrrolizidine alkaloids as substrates. The anaerobic mixed culture derived from
ovine rumen fluid (L4M2) was maintained on E medium in hungate tubes under
anaerobic conditions at 38 °C with serial transfers on a daily basis. Parallel cultures
were grown with different pyrrolizidine alkaloids as substrates.Samples were
removed from the cultures at appropriate time intervals and analyzed for
pyrrolizidine alkaloids and methylene products.
The E medium had the following composition: mineral I solution, 40 mUL;
mineral II solution, 40 mUL; major volatile fatty acid (VFA) solution, 11.4 mUL;
supplemental VFA solution, 11.4 mUL; trace metal solution, 11.4 mUL; 0.1%
resazurin, 1.1 mUL; 0.01% hemin (in 0.05 M NaOH), 1.1 mUL; clarified rumen fluid,
100 mUL; 8% sodium carbonate (w/v), 50 mUL; 2.5% cysteine hydrochloride (w/v),
10 mL/L; and 2.5% sodium sulfide (w/v), 6 mUL. The headspace gas was CO2.
The pH was adjusted to 7.0.The solutions of sodium carbonate, cysteine
hydrochloride and sodium sulfide were prepared as previously described (Bryant
and Robinson, 1961) and added after autoclaving as filter-sterilized solutions.
Mineral solution I contained K2HPO4, 6 g/L (Bryant and Robinson, 1961). Mineral92
solution II had the following components: NaCI, 12 g/L; KH2PO4, 6 g/L;(NH4)2SO4,
12 g/L; MgSO47H20, 1.0 g/L; and CaC122H20, 1.0 g/L (Bryantand Robinson,
1961). The major VFA solution had the following components: sodiumacetate,
20.82 g/L; sodium propionate, 9.6 g/L; and sodium butyrate, 5.5 g/L(Leedle and
Hespell, 1980). The supplemental VFA solution had the followingcomponents:
isobutyric acid, 10 mUL; 2-methylbutyric acid, 10 mUL; isovaleric acid, 10mUL;
and valeric acid, 10 mUL (Leedle and Hespell, 1980). The pH ofboth VFA
solutions was adjusted to 7.5 using NaOH. The trace metals solution hadthe
following components: Na2EDTA, 0.43 g/L; FeSO47H20, 0.20 g/L; MnSO4H20,
0.17 g/L; H3B03, 0.03 g/L; CoCl2.6H20, 0.012 g/L; ZnSO47H20, 0.01 g/L; NaMoO4,
0.0025 g/L; NiC126H20, 0.002 g/L; and CuC122H20, 0.001 g/L (Pfennig, 1965).
Chemicals
A crude mixture of pyrrolizidine alkaloids was isolated fromSeneciojacobaea
(tansy ragwort) as previously described (Liddell and Logie, 1993). This mixture
contains mostly jacobine and seneciphylline, although senecionine, integerrimine,
jacozine, jacoline, and retrorsine are all present (Figure 5.2). Integerrimine, which
is an isomer of senecionine, has not been reported previously in S.jacobaeaand
may be an artifact of the extraction procedure; isomerization may be occurring in the
methanol extract.Monocrotaline was purchased from Sigma.Heliotrine and
lasiocarpine were gifts from Dr. Edgar, CSIRO, Australia. The lasiocarpinewas
originally isolated prior to 1993, and currently consists of a mixture of angelyl and
tiglyl isomers, as well as two breakdown products (Figure 5.3). Thespontaneous93
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isomerization from angelyl to tiglyl esters has been observed for bothmono- and
diesters (Stelljes et al., 1991). Although the mass spectra for the angelyl andtiglyl
isomers of lasiocarpine were indistinguishable, identification (peaks 3and 4 in
Figure 5.3) was based upon the known elution order; angelyl isomerselute prior to
tiglyl isomers (Stelljes et al., 1991).Stock solutions of individual pyrrolizidine
alkaloids or the tansy pyrrolizidine alkaloid mixturewere prepared in phosphate
buffer (pH=6.8) and added to the growth media for a final concentration of 50- 100
pg/mL. Stock solutions of individual pyrrolizidine alkaloidsor the tansy pyrrolizidine
alkaloid mixture were prepared at a concentration of 10 mg/mL in methanol and
diluted into water to prepare the working standards.Each set of 4 working
standards ranged from 10 to 160 pg/mL and was used to quantitate samples
analyzed by GC/MS as described below.
TLC analysis
This method was modified from previously reported methods (Chapter 4;
Wachenheim et al., 1992a, 1992b). Samples (0.5 mL) were mixed with 5 M NaOH
(50 pL) and dichloromethane (1 mL). Samples were centrifuged (5 min) to separate
the layers. The dichloromethane was transferred toa clean glass tube (12x75 mm),
and then removed under vacuum at 43 °C. The residuewas reconstituted in
methanol (20 pL) and spotted in duplicate (2 x 10 pL) onto HPKF silica gel TLC
plates (Whatman). The plates were developed in eitheran acidic solvent system
(A) or a basic solvent system (B).Solvent system A consisted of chloroform-
methanol-propionic acid (36:9:5); solvent system B consisted ofchloroform-96
methanol-ammonium hydroxide (85:14:1). Individual plateswere then visualized
either with spray system C or spray system D. System C consisted of sequential
spraying with 1% o-chloranil in toluene and Ehrlichs spray reagent (Sigma), with
heating at 80 °C after each spraying; system D consisted of sequential spraying with
Dragendorff spray reagent (Sigma) and 5% aqueous sodium nitrite. The Rf values
of the pyrrolizidine alkaloids in both solvent systems are shown in Table 5.1, and the
detection limits (based on visual detection) of the pyrrolizidine alkaloids with both
spray systems are shown in Table 5.2.
Table 5.1 Rf values for pyrrolizidine alkaloids
developed in solvent systems A and B.
heliotrine
lasiocarpine
monocrotaline
tansy PA mixture
jacobine
seneciphylline
ND Not determined.
GC/MS analysis
A B
0.47 0.25
0.67 0.71
ND 0.42
0.70 0.59
0.80 0.62
Samples (1.0 - 3.0 mL) were mixed with concentrated NH4OH (100 pL) and
then extracted with dichloromethane (2 mL each). The dichloromethanewas
combined and then removed under vacuum at 43 °C.The residue was
reconstituted in ethyl acetate or toluene (200- 500 pL). Samples were97
Table 5.2 Detection limits for pyrrolizidine alkaloids
visualized with spray systems C and D (pg/mL).
heliotrine a
lasiocarpine b
monocrotalinea
total PA from tansy b
C D
6 4
10 8
8 4
10 6
aDetermined from plates developed in solvent system B.
bDetermined from plates developed in solvent system A.
chromatographed on an Rt-5MS capillary column (30-m x 0.25-mm, 0.5-pm film
thickness, Restek) installed in an HP 5890 GC (Hewlett-Packard) interfaced with a
Finnigan 5100 quadrupole mass spectrometer (El, 70 eV) (Finnigan). Samples
were injected by an HP model 7673A automatic injector into a split-splitless injector
operated in the splitless mode (injector temp. 200 °C, transfer line temp. 280 °C,
manifold temp. 100 °C). Three different oven programs were used (1, 2 and 3).
Program 1: 100 °C (3 min), 5 °C/min to 280 °C (5 min). Program 2: 100 °C (3 min)
10 °C/min to 280 °C (8.5 min). Program3: 150 °C(3 min) 5 °C/min to 280 °C (4.5
min), with a transfer line temp. of 250 °C. The scan range was 45-420 amu (0.19
s/scan). Data were collected via personal computer running Galaxy 2000 software
(LGC).98
Derivative formation
Mass spectral data are consistent with the hypothesis that heliotrine is
converted to 7a-hydroxy-1-methylene-8a-pyrrolizidine (Figure 5.1). The metabolite
produced in cultures grown on heliotrine was converted to the heptafluorobutyrate
derivative as follows. Selected samples from cultures of both P. heliotrinreducens
and L4M2 grown on heliotrine were extracted, as described under GC/MS analysis,
andreconstitutedintoluene(1.0mL). Thederivatizationreagent
heptafluorobutyrylimidazole (HFBI) was added (100 pL), and the samples vortexed
and heated at 70 °C for 30 min in a block heater. To remove excess derivatization
reagent, 1 mL of water was added and the samples were vortexed and centrifuged
at 1520 RCF for 5 min. The organic layer was then concentrated (to 100 pL) and
analyzed via GC/MS with temperature program 1. Shown in Figure 5.4 are the
mass spectra of this compound before and after derivatization. Shown are data
from cultures of P. heliotrinreducens grown on heliotrine; cultures of L4M2 grown
on heliotrine yielded equivalent results.
Preparative TLC
Mass spectral data are consistent with the hypothesis that lasiocarpine is
converted to 7a-angelyI-1-methylene-8a-pyrrolizidine (Figure 5.1). The metabolite
produced in cultures grown on lasiocarpine was isolated using preparative TLC of
selected cultures of both P. heliotrinreducens and L4M2 grown on lasiocarpine.
Samples (5 -10 mL) were mixed with 5 M NaOH (0.5- 1.0 mL) and extracted with99
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Figure 5.4 Mass spectra. A) 7a-hydroxy-1-methylene-8a-pyrrolizidine. MW 139.
B) Heptafluorobutyrate derivative of 7a-hydroxy-1-methylene-8a-pyrrolizidine.
MW 335.100
dichloromethane (10- 15 mL). The dichloromethane was then removed under
vacuum. The residue was dissolved in methanol and streaked onto HPKFsilica gel
TLC plates (Whatman). After the plateswere developed in solvent system A, they
were completely covered except for 1 cm, which was visualized withspray system
D. After location of the product, the silicaon the unsprayed portion of the plate was
scraped off of the glass plate (Rf = 0.68- 0.80) and placed on top of a plug of glass
wool in a Pasteur pipet. The productwas eluted with 3 1-mL aliquots of chloroform-
methanol (3:1) followed by 1 mL of methanol. The solventwas removed under
vacuum; the residue was reconstituted in toluene and analyzed by GC/MSwith
temperature program 2. A small amount of 7a-tiglyl -1-methylene-8a-pyrrolizidine
was also identified (Figure 5.5). The mass spectra for the angelyl and tiglyl isomers
were indistinguishable and are consistent with that previously reported for the 7(3-
angelyl- isomer (Logie et al., 1997).Identification was based upon the known
chromatographic elution order (angelyl isomers elute before tiglylisomers) (Stelljes
et al., 1991). The data shown in Figure 5.5 is from cultures of P.heliotrinreducens
grown on lasiocarpine; cultures of L4M2 grown on lasiocarpine yielded equivalent
results.
RESULTS AND DISCUSSION
TLC analysis was used as a rapid method to monitor eachcultures ability to
metabolize pyrrolizidine alkaloids, and also to determine ifmethylene compounds
were being produced.The majority of the pyrrolizidine alkaloids typically
chromatographed better in the basic solvent system thanin the acidic solvent, but101
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Figure 5.5 Analysis results of preparative TLC. A) GC/MS total ion
chromatogram showing 7a-angely1-1-methylene-8a-pyrrolizidine (1) and
7a-tigly1-1-methylene-8a-pyrrolizidine (2). Chromatographic conditions
described in the text under temperature program 2. B) Mass spectra of
compound (1). MW 221.102
the tansy pyrrolizidine alkaloids did not fully separate in the basic solvent system
and lasiocarpine separated from its methylene product better in the acidic system.
The pyrrolizidine alkaloids used in this study were visible with both spray systems.
However, since system C is selective for unsaturated pyrrolizidines and system D
will visualize any amine, any methylene compounds formed were visible only with
system D. Shown in Table 5.3 are the Rf values for the methylene products. The
TLC analysis did not detect any 1-methylene compounds in the cultures of L4M2
grown on monocrotaline or tansy pyrrolizidine alkaloids, or in the cultures of P.
heliotrinreducens grown on tansy pyrrolizidine alkaloids. As monocrotaline has 6-
stereochemistry at C7, it is presumed that it's 1-methylene product does as well.
Table 5.3 Rf values for 1-methylene products developed in solvent systems A
and B.
A
7 a-angely1-1-methylene-8a-pyrrolizidinea
7a-hydroxy-l- methylene- 8 a- pyrrolizidine"
7 13-hydroxy-l-methylene-8 a-pyrrolizidine`
0.75 0.74
dND 0.10
dND 0.10
'Produced in cultures of both P. heliotrinreducens and L4M2 grown on lasiocarpine.
'Produced in cultures of both P. heliotrinreducens and L4M2 grown on heliotrine.
Produced in cultures of P. heliotrinreducens grown on monocrotaline.
dND Not determined.
Samples taken from one culture over time were analyzed and quantitated
with GC/MS to confirm the disappearance of the pyrrolizidine alkaloids over time
and the appearance of the 1-methylene products over time. Shown in Figure 5.6103
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Figure 5.6 GC/MS analysis results from cultures growing on heliotrine.
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are the results from the cultures grown on heliotrine.P. heliotrinreducens
metabolized the heliotrine completely within 16 hr, with production of 7a-hydroxy-1-
methylene-8a-pyrrolizidine reaching a maximum in 16 hr and then leveling off. A
lag time of about 5 hr was observed in both the metabolism of the heliotrine and in
the production of the 1-methylene product. The L4M2 culture metabolized the
heliotrine completely within 8 hr, with production of 7a-hydroxy-1-methylene-8a-
pyrrolizidine stabilizing after about 5 hr. In the sterile controls for both cultures, the
heliotrine concentration remained relatively constant throughout the 24-hr period;
the slopes were -0.99 and -0.27 pg/mUhr in the cultures of P. heliotrinreducens and
L4M2, respectively. No 1-methylene compounds were detected at any time in the
sterile controls.
Shown in Figure 5.7 are the results from the cultures grown on lasiocarpine.
The lasiocarpine concentration represents the total of all 4 compounds present in
the initial material (Figure 5.3).The P. heliotrinreducens metabolized the
lasiocarpine completely within 16 hr, with production of both 7a-angelyI-1-
methylene-8a-pyrrolizidine and 7a-tiglyI-1-methylene-8a-pyrrolizidine reaching a
plateau in 16 hr. A lag time of about 5 hr was observed in both the metabolism of
the lasiocarpine and in the production of the 1-methylene products. The L4M2
culture metabolized the lasiocarpine completely within 5 hr, with production of both
7a-angely1-1-methylene-8a-pyrrolizidine and 7a-tiglyI-1-methylene-8a-pyrrolizidine
reaching a maximum in 8 hr and then leveling off.In the sterile controls for both
cultures, the lasiocarpine concentration remained relatively constant throughout the
24-hr period; the slopes were 0.74 and 0.28 pg/mUhr in the cultures of P.E2 160 -A
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heliotrinreducens and L4M2, respectively.No 1-methylene compounds were
detected at any time in the sterile controls.
Shown in Figure 5.8 are the results from the P. heliotrinreducens and L4M2
cultures grown on tansy pyrrolizidine alkaloids. The tansy pyrrolizidine alkaloids
concentration represents the total of all 7 compounds present in the initial material
(Figure 5.2). The cultures of P. heliotrinreducens did not metabolize the tansy
pyrrolizidine alkaloids within the 24-hr period; the slopes were -0.38 and -0.04
pg/mUhr in the viable culture and the sterile control, respectively. No 1-methylene
compounds were detected in any of the samples at any time.Analysis of P.
heliotrinreducens cultures that were allowed to incubate for longer periods (up to
12 days) also indicated that no metabolism of these pyrrolizidine alkaloids occurred.
The inability of P. heliotrinreducens to metabolize the macrocyclic pyrrolizidine
alkaloids isolated from tansy ragwort is consistent with previous results (Lanigan,
1976).
With L4M2, the tansy pyrrolizidine alkaloids were completely metabolized
within 12 hr, with production of a small amount of 73- hydroxy -1- methylene -8a-
pyrrolizidine increasing throughout the 24-hr period (Figure 5.8B).The mass
spectra for the 7a- and 76-hydroxy-1-methylene-8a-pyrrolizidine compounds are
essentially identical (Figure 5.4A). All of the pyrrolizidine alkaloids in the mixture
isolated from tansy have 6-stereochemistry at C7 (Figure 5.2); therefore, it is
presumed that the 1-methylene product does as well.In the sterile controls for
L4M2, the concentration of tansy pyrrolizidine alkaloids remained relatively140
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constant throughout the 24-hr period (slope = 0.27 pg/mUhr) andno 1-methylene
compounds were detected at any time.
Shown in Figure 5.9 are the results from the P. heliotrinreducens and L4M2
cultures grown on monocrotaline. The cultures of P. heliotrinreducens did not
metabolize the monocrotaline within the 24-hr period; the slopes were 0.56 and
-0.33 pg/mUhr in the viable culture and the sterile control, respectively. Trace
amounts of 78-hydroxy-1-methylene-8a-pyrrolizidine were detected in the viable
cultures at 16 and 24 hr. Analysis of P. heliotrinreducens cultures that were allowed
to incubate for longer periods indicated that metabolism of monocrotaline occurred
with production of higher amounts of 7f3-hydroxy-1-methylene-8a-pyrrolizidine,
although inconsistently; complete metabolism of monocrotaline required anywhere
from 6 to 23 days, and not all replicates metabolized monocrotaline.
For the L4M2 culture, monocrotaline was completely metabolized within 12
hr, with production of 78-hydroxy-1-methylene-8a-pyrrolizidine (Figure 5.9B). Due
to the large degree of scatter in the results of the product peak area, it is impossible
to determine from this data if the amount of product is stable or if it is changing.
However, this data was useful in confirming the 8-stereochemistry of the product
at C7. These samples were analyzed using the same GC program as the samples
from the cultures grown on heliotrine (temperature program 2). The 7a-hydroxy-1-
methylene-8a-pyrrolizidine produced in the cultures grown on heliotrine eluted at
9.10 min (standard deviation = 0.02 min).The 713-hydroxy-1-methylene-8a-
pyrrolizidine produced in the cultures grown on monocrotaline eluted at 7.85 min
(standard deviation = 0.01 min). As previously mentioned, themass spectra of120
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these two compounds is essentially identical; thus, the significant difference in
retention time indicates different stereochemistry. Identification of the early eluting
peak as the p- isomer is based upon the known chromatographic elution order of
necine bases; the GC retention time of heliotridine (C7-a and C8 -a) is greater than
that of retronecine (C7-13 and C8-a) (Stelljes et al., 1991). In the sterile controls for
L4M2, the concentration of monocrotaline remained relatively constant throughout
the 24-hr period (slope = -0.91 pg/mUhr) and no 1-methylene compounds were
detected at any time.
To summarize, the experimental data are consistent with the predicted
metabolism of heliotrine (a mono-ester) and lasiocarpine (a diester) to the 1-
methylene compounds by both P. heliotrinreducens and the mixed culture L4M2
(Figure 5.1). The macrocyclic pyrrolizidine alkaloids isolated from tansy ragwort
were not metabolized by P. heliotrinreducens; these same pyrrolizidine alkaloids
were metabolized rapidly by L4M2 with production of very low levels of the
corresponding 1-methylene compound. The macrocyclic pyrrolizidine alkaloid
monocrotaline was metabolized by P. heliotnnreducens inconsistently (either slowly
or not at all); L4M2 metabolized monocrotaline rapidly with production of the
corresponding 1-methylene compound.
The mixed culture L4M2 has displayed more variety than the single organism
P. heliotrinreducens, both in the type of pyrrolizidine alkaloids metabolized and in
the final products. Although P. heliotrinreducens shows a preference for mono- or
di-ester pyrrolizidine alkaloids, it still requires a lag time before effective metabolism
occurs. This is in contrast to L4M2, for which a lag time was not observed during111
metabolism of any of the pyrrolizidine alkaloids. Because all of themono- and di-
ester pyrrolizidine alkaloids used in this study had a-stereochemistry at C7, and all
of the macrocyclic pyrrolizidine alkaloids used had 8-stereochemistry at C7, it is not
clear which featureis more importantin terms of metabolism byP.
heliotrinreducens.In all of the cases in which P. heliotrinreducens metabolized
pyrrolizidine alkaloids, experimental data were consistent with the predicted 1-
methylene compounds which were produced as end-products.
L4M2 appears to have produced 1-methylene compounds as end-products
in some cases, but possibly as intermediates in others. L4M2 grown on heliotrine
seems to produce 7a-hydroxy-1-methylene-8a-pyrrolizidine as an end-product;
within the 24-hr period monitored its concentration appears to stabilize. L4M2
grown on lasiocarpine seems to produce 7a- angelyl -1- methylene -8a- pyrrolizidine
as an end product, although it is unclear if the maximum peak area observed at 8
hr is due to further metabolism or random error in the assay. This same trend was
observed in duplicate cultures.
Experimental data indicates that L4M2 grown on the tansy pyrrolizidine
alkaloids produces 713-hydroxy-1-methylene-8a-pyrrolizidine, although at much
lower levels than in any of the other cultures; its peak area is at least 10 times less
than that of the 7a- isomer produced in cultures of L4M2 grown on heliotrine. Due
to the very low levels produced it is difficult to conclude if the concentration of 713-
hydroxy-1-methylene-8a-pyrrolizidine is increasing throughout the 24-hr period, or
if it has reached a maximum at 12 hr and then stabilized. Either way, metabolism112
of these pyrrolizidine alkaloids by L4M2 appears to produce 1-methylene
compounds as intermediates.
Currently ongoing experiments in this laboratory are directed at identifying
individual organisms present in the L4M2 group using 16S rRNA methodology.
Preliminary results indicate that L4M2 does not include an organism belonging to
the Peptostreptococcus genus. This implies that pyrrolizidine alkaloid metabolizing
behavior is not unique to one genus and may be common to several different
genera.
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Chapter 6
SUMMARY
The work presented herein centered around providing direct evidence ofthe
specific metabolites of the macrocyclic pyrrolizidine alkaloids jacobineand
seneciphylline produced during incubation with ovine ruminal microorganisms.
Preliminary work had indicated that metabolites containinga necine base ring
system were not being produced. Two specific metabolic pathways involving the
necine base ring system were investigated. The first pathway studied focusedon
hydrolysis of jacobine and seneciphylline followed by metabolism of the necine
base. Hydrolysis was not observed in either sheep whole rumen fluidor with the
mixed culture L4M2, nor was metabolism of the necine base independent of the
parent alkaloids observed. The second pathway studied involved the production of
compounds in which the necine base had been modified by the conversion of the
1,2-double bond to an external methylene group. This pathway yielded interesting
results, with jacobine and seneciphylline being converted to 1-methylene
compounds by the mixed culture L4M2, although with low yields.L4M2 also
converted heliotrine and lasiocarpine to 1-methylene compounds as end products.
L4M2 has demonstrated the ability to metabolize a greater variety of pyrrolizidine
alkaloids than the single organism Peptostreptococcus heliotrinreducens. As the
mono- and di-ester pyrrolizidine alkaloids used inthis study allhad a-
stereochemistry at C7 and the macrocyclic pyrrolizidine alkaloids all had 13-115
stereochemistry at C7, it is not clear which structural featuredetermines the extent
of metabolism by P. heliotrinreducens.Neither feature affected the extent of
metabolism by L4M2, although they are likely influencing theend product formation.
Although L4M2 was originally derived from the ovinerumen fluid of sheep
maintained on a diet of Seneciojacobaea, it is likely that theseanimals would be
resistant to a variety of toxic plants which contained thepyrrolizidine alkaloids
monocrotaline, heliotrine and lasiocarpine.
Future experiments should include the determination oferror (relative
standard deviation) in the GC/MS analysis of the various pyrrolizidinealkaloids, and
if possible in the GC/MS analysis of the methylene product.Error in these assays
could be reduced by the utilization of an injection internal standard.Data on the
methylene product in this study is difficult to interpret; it is not alwayspossible to
distinguish between a plateau or a maximum in the amount of methylenecompound
produced. Making a derivative of the methylene productmay improve this assay,
especially at low levels, but it would then be difficult to obtain dataon the parent
pyrrolizidine alkaloid concentration in thesame analysis.Quantitation of the
methylene product was not an available option in this study becausea standard was
not available.Heliotrine and lasiocarpine are not available in quantities large
enough to isolate a large amount of product. Synthesis of methylenecompounds
may be an option, although separation from co-products is difficult and yieldsare
low.
Further studies could also investigate the influence ofstereochemistry and
structure on pyrrolizidine alkaloid metabolism by L4M2. Usingmono- or diester116
pyrrolizidine alkaloids with 6-stereochemistry at C7 would help determine the
influence of structure on the metabolites. As almost all macrocyclic pyrrolizidine
alkaloids have I3-stereochemistry at C7, the study of pyrrolizidine alkaloids witha-
stereochemistry at C7 would be limited to mono- and diester pyrrolizidine alkaloids.
Confirmation that 1-methylene compounds are intermediates, would verify
that ruminal metabolism detoxifies pyrrolizidine alkaloids. The 1,2-double bond in
the necine base is necessary for pyrrolizidine alkaloid toxicity because it enhances
the conversion to the toxic pyrroles. The 1-methylene compounds do not form
pyrroles with the oxidizing reagent o-chloranil and likely would not form pyrroles in
the liver either.Although P. heliotrinreducens converts selected pyrrolizidine
alkaloids to 1-methylene compounds, ovine rumen fluid from Australian sheep will
further metabolize these compounds, converting the methylene to a methyl group.
It should be determined if L4M2, which may utilize 1-methylene compounds as
intermediates in the metabolism of jacobine and seneciphylline, is producing
compounds with a 1-methyl group.
Currently ongoing experiments in this laboratory are directed at identifying
the individual microorganisms present in the L4M2 group using 16S rRNA
methodology. Preliminary results indicate that L4M2 does not include an organism
belonging to the Peptostreptococcus genus. This implies that pyrrolizidine alkaloid
metabolizing behavior is not unique to one genus and may be common to several
different genera.117
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